







































Preterm infants have an immature respiratory system and therefore experience an increased 
number of respiratory pauses and oxygen desaturations. There is now advanced pulse 
oximetry technology that can record oxygen saturations every two seconds for extended 
periods of time. There has been insufficient literature that reports the incidence of 
intermittent hypoxia at time of discharge home from the neonatal unit in preterm infants 
using new generation oximeters. These respiratory events preterm infants experience have 
been shown to have some effect on neurodevelopment, but their effect on growth has not 
been investigated before. The primary aim of this study was to determine the prevalence of 
intermittent hypoxia in preterm infants at time of discharge home from the neonatal unit. 
The study also addresses the issue of artefact within oximetry recordings and compares 
results from automatically edited, manually edited and unedited oximetry data, as well as 
determining whether overnight 12-hour recordings are of equal value to full 24-hour 
recordings. The secondary aim of this study was to determine whether intermittent hypoxia 
at discharge has any effect on post discharge growth and to determine changes in amount 
of intermittent hypoxia from discharge oximetry to oximetry one-month post discharge.   
 
We recruited preterm infants from the Wellington neonatal intensive care unit. A 24-hour 
pulse oximetry recording was performed immediately prior to the infant’s discharge home. 
These oximetry recordings were analysed and median values for measures reported from 
oximetry recordings were determined. Rules to manually edit oximetry data were created 
and applied to oximetry recordings. These manually edited reports were then compared 
with automatically edited and unedited reports. Each recording was also edited to resemble 
a 12-hour overnight recording and this was compared to the full 24-hour recording. Infants 
born less than 32 weeks gestational age were further followed up with weekly growth 
measurements for one-month. A repeat 24-hour oximetry recording was performed at one-
month post discharge for these infants and compared to their discharge recording. 
	
We report high rates of intermittent hypoxia in preterm infants at time of discharge home 
from the neonatal unit. For example the median 4% oxygen desaturation index (DSI 4%). 
was 57.9 events per hour. The incidence of these events decreased with advancing post-
menstrual age. Rates of intermittent hypoxia one month post discharge were greatly 
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decreased from discharge with improvements of 42% - 57% seen, with DSI 4% reducing to 
25.5 events per hour. This study did not show a significant association between 
intermittent hypoxia and post-discharge growth, possibly because of the small sample size 
in this study subgroup.  
	
There were few clinically relevant differences on reports edited manually compared with 
automatically edited reports, with some difference when compared to unedited reports. We 
recommend automatically editing oximetry reports as this gives similar results to manual 
editing for the majority of measures, however the nadir of the fall in oxygen saturation is 
often artefact, and even after automatic editing is the one measure that may remain false. 
The 24-hour oximetry reports were clinically similar to 12-hour recordings and therefore 
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Preterm infants experience many complications as a result of being born with immature 
physiological systems. One of these is an immature respiratory centre and lungs which 
leads to vulnerability with regard to pauses in breathing and hypoxia. 
 
This thesis investigates the incidence of intermittent hypoxic episodes on oxygen 
saturation recordings in preterm infants at their time of discharge from the neonatal unit. It 
also examines whether intermittent hypoxia at discharge can predict growth rates in these 
preterm infants in the first month post discharge.  
 
During the progression of this thesis, the concern of how artefact affects oxygen saturation 
recordings, and exactly how to best edit this artefact became an issue. It was apparent after 
talking with experts in this field that the issue of artefact in oxygen saturation recordings 
has not been well addressed previously and there were no clear guidelines on how to edit 
these recordings or how editing of reports would affect any values reported. Therefore, this 
thesis evolved to also investigate methods of editing oxygen saturation recordings and the 
overall effect this has on measures reported. The question was also raised as to whether 
there was any benefit of performing a full 24-hour oxygen saturation recording over an 
overnight 12-hour recording, therefore this thesis also determines whether there are any 







2.1 The problem of prematurity 
Preterm birth is defined by the World Health Organisation (WHO) as the birth of an infant 
at less than 37 weeks gestational age (GA). There are a total of 15 million preterm infants 
born worldwide each year (1). In New Zealand (NZ) the proportion of infants born preterm 
was 7.4% in 2014, which remains unchanged from 2011(2).  
 
There are many reasons an infant may be born prematurely, with 75% of preterm births 
occurring spontaneously (3). This may be the result of premature rupture of membranes 
and or preterm labour due to maternal complications such as infection, incompetent cervix 
or placenta praevia. Fetal medical conditions such as congenital abnormalities or growth 
restriction as well as pre-eclampsia may indicate the need for an induction of labour 
prematurely. Other risk factors for preterm birth include smoking, recreational drug use, 
multiple gestation, pregnancy in woman <18 or >40 years and maternal medical conditions 
such as diabetes and hypertension (3).  
 
Being born prematurely places an infant at a significantly increased risk of a number of 
serious morbidities and mortality. The earlier GA an infant is born, the greater the risk of 
complications occurring. Preterm infants can be grouped according to level of maturity: 
extremely preterm (less than 28 weeks GA), very preterm (28 to 32 weeks GA) and 
moderate to late preterm (32 to 37 weeks GA). Data from the Australian and New Zealand 
Neonatal Network's (ANZNN) 2013 report show that survival rates to discharge from the 
neonatal intensive care unit (NICU) for infants born ≤ 24 weeks GA is 56.9%, and 
increases with each week gestation to 97.4% for infants born at 30 weeks GA (4). 
 
All body systems are immature when an infant is born premature, therefore all systems are 
vulnerable to complications. The brain is at risk of intraventricular haemorrhage (IVH) and 
the eyes at risk of developing retinopathy of prematurity (ROP). The heart is more likely to 
have a persistent patent ductus arteriosus (PDA) and necrotising enterocolitis (NEC) is 
more much more common in preterm infants. However perhaps the most common system 
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with which preterm infants experience complications is the respiratory system. Respiratory 
distress syndrome (RDS) is primarily caused by a deficiency of surfactant (a substance that 
reduces surface tension and prevents lung collapse), and results in respiratory 
insufficiency. It is very common in very preterm infants with its rate of occurrence 
inversely related to increasing GA, with 100% of infants born less than 26 weeks GA, 57% 
of infants born less than 32 weeks GA, and only 3.7% of infants at 36 weeks GA 
experiencing RDS (5). Steroids are given antenatally when a mother is likely to deliver 
prematurely to help reduce the incidence and severity of RDS and infants receive 
exogenous surfactant after birth for treatment if they are symptomatic. 
 
Preterm infants often require addition inspired oxygen and ventilatory assistance to support 
their respiratory effort and maintain their arterial oxygen saturations (SaO2) in the desired 
range. Continuous positive airway pressure (CPAP) is commonly used in the NICU, and 
for some very preterm or sick infants, endotracheal intubation and ventilation is required. 
Some preterm infants can develop bronchopulmonary dysplasia (BPD) (also known as 
chronic lung disease (CLD)), which is generally defined as the ongoing need for additional 
inspired oxygen at 36 weeks postmenstrual age (PMA) with an abnormal chest x-ray. 
Although not all preterm infants experience these more serious respiratory complications, 
it has been recognised that all preterm infants do experience a greater number of apnoea 
(broadly defined as a pause in breathing) and oxygen desaturations compared to term 
infants (6, 7). If there is no clear underlying cause for these respiratory events, they are 
usually termed Apnoea of Prematurity (AOP). It is the issue of the episodic intermittent 
oxygen desaturation that is associated with these short respiratory pauses, in particular the 
presence of these events prior to preterm infants discharge home, that this thesis focuses 
on. 
 
Neonatal units have a responsibility to provide these vulnerable infants with expert care 
and treatment. An infant born at 26 weeks GA may spend their first three months of life in 
NICU. As preterm infants age, their respiratory centre matures and they can slowly be 
weaned off ventilation and additional inspired oxygen. During the final weeks in NICU 
they learn to suck and swallow safely and feed by breast or bottle rather than being fed by 
nasogastric (NG) tube. An infant is ready for discharge home when they can maintain their 
SpO2 in the normal range, regulate their temperature, and are feeding and growing 
satisfactory. For extremely preterm infants this may be at a PMA of 39-42 weeks. A 
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moderate to late preterm infant may only spend one week or two in NICU and some are 
discharged home at a PMA of 36-37 weeks, providing they are able to reach the milestones 
as listed above. The American Academy of Pediatrics (AAP) 2008 policy statement on 
Hospital Discharge of the High-Risk Neonate states that the three physiologically 
competencies that should be met before discharge home are “oral feeding sufficient to 
support appropriate growth, the ability to maintain normal body temperature in a home 
environment, and sufficiently mature respiratory control". They do not mention 
specifically how an infant’s respiratory control should be measured to determine its 
‘maturity’ however they do recommend all high-risk infants have a car seat evaluation for 
physiological stability prior to discharge home (8). 
 
As well as the complications of prematurity seen in NICU patients there is also an 
increased risk of long-term complications after discharge. Severe disabilities such as 
blindness, deafness, and cerebral palsy (CP) are becoming less common, but remain a 
common complication for extremely preterm infants. Data on CP rates from a 2008 meta-
analysis reported that 14.6% of extremely preterm infants, 6.2% of very preterm infants 
and 0.7% of infants born older than 34 weeks GA develop CP (9). Local NZ and 
Australian data indicate that 8% of extremely preterm infants develop CP (4). Cognitive 
impairment (IQ<70) is also more common in preterm infants compared with term infants. 
Overseas data indicate that approximately one third of all preterm infants have some 
cognitive impairment, while local ANZNN data indicate that 14.6% of infants have some 
cognitive impairment (4, 10). Preterm infants are more likely to be smaller than term 
infants long term with local ANZNN data reporting that 19.1% of very preterm infant 
weights are <3rd percentile at 2-3 years corrected age (4). Preterm infants also have more 
long-term cardiorespiratory problems, with twice as many cardiovascular malformations 
than term infants (11). The reason for this is both due to consequences of preterm birth and 
due to cardiac malformations causing premature birth. However, despite these serious 
complications many preterm infants do very well.  
 
Preterm infants are likely to need ongoing medical and developmental care and follow up. 
This means they have a continuing cost to the medical system, as well as a having a large 
impact emotionally on the patient and their family. There has been considerable 
improvement in the area of preterm infant mortality and severe morbidity over recent years 
and research efforts are now focusing on further understanding mild morbidity and thereby 
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further improving long-term outcomes; therefore, this thesis focuses on intermittent 
hypoxia in the presence of normal mean oxygen saturations.  
	
	
2.2 Respiratory pauses, bradycardia, and oxygen desaturation in 
preterm infants 
Respiratory pauses, bradycardia, and episodic oxygen desaturation are common issues 
encountered in the neonatal unit. They are closely interlinked, with a respiratory pause 
often causing a decrease in SaO2. Bradycardia is commonly defined in preterm infants as a 
heart rate of less than 100 beats per minute (bpm) or a drop of greater than one third of 
baseline heart rate (12, 13). Bradycardia is frequently seen in association with respiratory 
pauses and oxygen desaturation. The bradycardia component has been shown to typically 
occur after the oxygen desaturation, most likely because of reflex bradycardia mediated via 
the carotid chemoreceptors (12, 14). 
 
The rate at which SaO2 falls and the SaO2 nadir for each oxygen desaturation event varies 
between infants and depends on multiple factors including: baseline oxygen saturation, 
lung volume, metabolic rate, haemoglobin concentration, blood volume, and the presence 
of intrapulmonary shunting (13, 15). As preterm infants have a small lung volume, higher 
metabolic rate and a small blood volume, a relatively short pause in breathing (a few 
seconds) may be followed by a significant drop in SaO2 particularly if the infant is further 
compromised by CLD. Extremely premature infants often experience many of these 
respiratory events, however more mature infants with CLD also experience these events, 
right through to well, late preterm infants that are close to being discharged home and less 
commonly, term infants (16).  
 
Previously, respiratory pauses have been the focus of research, however now there is more 
refined technology to measure oxygenation the interest has shifted to the associated 
episodic oxygen desaturations. Elder et al. compared respiratory recordings of preterm 
infants with clinical concern for apnoea to those without and found that the differences lay 
in the degree of episodic oxygen desaturation rather than the type or duration of apnoea 
and noted that monitoring of oxygen saturation is likely to give a better indication of 
	 6	
clinically significant respiratory events than monitoring breathing movements alone in 
preterm infants that are about to be discharged home (17). 
2.2.1 Control of respiration and respiratory variability in preterm infants  
The respiratory ‘centre’ lies in the brainstem. The central pattern generator for respiratory 
rhythm has been shown, by isolating brainstem sections, to be an area called the pre-
bötzinger complex in the ventrolateral medulla (18-20). Although the pre- bötzinger 
complex is the ‘centre’, there are many mechanisms that integrate into the respiratory 
centre that can alter the generated natural rhythm as well as influence the rate and tidal 
volume. Central and peripheral chemoreceptors detect carbon dioxide (CO2) and oxygen 
(O2) blood concentrations and feed back to alter minute ventilation (respiratory rate 
multiplied by tidal volume). Pulmonary stretch receptors in the lung also provide feedback 
to the respiratory centre. Higher central nervous system centres can override the respiratory 
centre, such as the consequences of emotion via the limbic system and sensory input. 
Temperature, sleep state and feeding also all affect respiration. Some of these mechanisms 
will be discussed in detail below, with particular reference to the preterm infant.   
i. Chemoreceptors 
The main peripheral chemoreceptors lie in the carotid and aortic bodies and primarily 
detect changes in O2, accounting for 90% of the ventilator response to hypoxaemia (21). At 
birth, peripheral chemoreceptors do not initially play a role in regulating respiration, as 
shown by an infant’s respiratory rate not reducing as expected when exposed to hyperoxia 
(13). This is thought to be because of the sudden increase in SaO2 at birth that ‘stuns’ the 
peripheral chemoreceptors. The peripheral chemoreceptors take 48-hours to reset, with 
their sensitivity gradually increasing (22). After this initial 48-hour resetting process, 
infants rely on peripheral chemoreceptor sensitivity over central chemoreceptor activity 
more than adults (21). Infants exhibit a biphasic ventilatory response to hypoxia, which is 
characterised by an initial increase in ventilation, followed by a decline to or below initial 
baseline ventilation levels. This biphasic response is more pronounced in preterm infants 
than term infants and gradually develops into the normal sustained ventilatory response to 
hypoxia as they mature (13).  
 
The main central chemoreceptors involved in respiratory control are situated on the ventral 
medulla and respond primarily to changes in CO2, mediated by changes in pH in the 
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cerebrospinal fluid (CSF). This hypercapnic ventilatory response is reduced in infants 
compared to adults, and also reduced in preterm infants compared to term infants with 
sensitivity increasing with advancing PMA (22). The CO2 threshold for initiating apnoea in 
preterm infants is very close to their baseline CO2, being only 1 – 1.3mnHg above baseline 
CO2. The CO2 threshold in term infants and adults is much higher (23, 24).   
ii. Influence of Sleep state  
Sleep state has a significant impact on respiratory variables in infants. Infant sleep states 
can be broadly classified into active sleep (AS) (similar to rapid eye movement (REM)) or 
quiet sleep (QS) (equivalent of non-REM). There is also a smaller proportion of sleep that 
cannot be categorised into either state, and is therefore termed intermediate sleep. Term 
infants spend a large proportion of their total sleep time in active and intermediate sleep. 
This proportion decreases with PMA, therefore the amount of time in QS increases with 
advancing age (25). Preterm infants spend an even greater proportion of total sleep time 
(TST) in AS, with a 31 week GA infant spending 90% in AS compared to a term infant 
who on average spends 50% of TST in AS (26, 27). In AS the tonic activity of respiratory 
muscles is absent and upper airway muscles are also more relaxed. There is irregular 
respiration and a higher rate of respiration in AS, compared to QS during which respiration 
is more regular (21). These are likely reasons why an infant experiences more overt apnoea 
and oxygen desaturation during AS compared to QS.  
iii. Influence of feeding 
Preterm infants initially have poor coordination between their suck, swallow and breathing 
pattern. This often resolves by term corrected age (13). 
The laryngeal chemo-reflex in term infants is a normal protective reflex where breathing 
ceases when fluid hits the pharynx or larynx to protect the airway, however in a preterm 
infant this response is exaggerated and this can lead to prolonged apnoea during feeding 
(28). It has been previously thought that infants with gastro-oesophageal reflux (GOR) are 
at increased risk for apnoea, however many studies have now shown that the temporal 
timeline does not fit, as the drop in pH associated with GOR occurs after the initiation of 
apnoea (29). Further adding to the argument of there being no association is that treatment 




iv. Influence of sleep position 
Some neonatal units nurse infants prone as early studies suggested this improves 
oxygenation and lung function for preterm infants, especially those with residual 
respiratory disease (33-35). More recent literature however suggests that these earlier 
studies did not control for sleep state, and when sleep state is controlled for, differences in 
lung function between prone and supine positioning disappear (36-38). It is now widely 
accepted that the recommended sleeping position for any preterm infant once at home is 
the supine sleeping position as it decreases the risk of sudden unexplained death in infancy 
(SUDI) and this should be modeled prior to discharge (39, 40).  
v. Summary 
Table 2-1 Main physiological factors influencing respiration in preterm infants 
Decreased chemo-sensitivity to both O2 and CO2 
Biphasic hypoxic response curve 
Baseline CO2 that is close to apnoea threshold 
Exaggerated laryngeal response 
Increased time in Active Sleep  
Less muscle and smaller lung volume 
2.2.2 Apnoea 
Apnoea can be used generally to mean cessation of breathing, however ‘apnoea’ when 
referred to as clinically significant is often defined by a minimum respiratory pause length 
and this clinical definition is problematic as it can differ considerably. The AAP define 
apnoea in infants as a sudden cessation of breathing that lasts at least 20 seconds (s), or 
less if is accompanied by bradycardia or oxygen desaturation (41). The degree of 
bradycardia or oxygen desaturation that would be of concern is not specified. There are 
also many other definitions for apnoea in this context. A review by Elder et al. of 93 papers 
studying infant apnoea found that definitions of apnoea length varied widely from ≥2 s to 
≥20 s (42).  Mathew et al. also reported the definition for required length varies from ≥5 to 
≥20 s (13). 
	
Although there is widespread debate and uncertainty about the length of a respiratory 
pause that is of sufficient clinical relevance to be termed an ‘apnoea’, clinicians do 
commonly use the definition of a pause of ≥20 s and apnoea alarms both in the NICU and 
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those used at home after discharge are often set to alarm after no breathing is detected for 
15 – 20 seconds (42). For the remainder of this thesis the term ‘apnoea’ will be used to 
refer generally to pauses in breathing that are thought to be clinically significant.  
i. Types of apnoea 
Apnoea can be classified into three subtypes: 
 
Central apnoea is where there is no inspiratory effort, therefore no chest wall movement 
and no airflow at the nose and mouth.  
 
Obstructive apnoea is where there is inspiratory effort and chest wall movement but there 
is no resultant airflow due to an obstruction of the upper airway (normally soft tissue).  
 
Mixed apnoea is where there is a central apnoea followed by inspiratory effort, but no 
airflow throughout.  
 
In preterm infants >50% of apnoea are mixed, 40% are central and only 10% are purely 
obstructive (28, 43). In older children, it is normally obstruction from soft tissue (e.g 
Adenoids/tonsils) that causes apnoea.  
ii. Periodic Breathing 
Periodic breathing (PB) is a breathing pattern defined as consisting of at least three 
consecutive apnoea that last three to ten seconds, with periods of up to 20 seconds of 
normal respiration separating them (44). The respiratory rate is normally high in the 
normal respiration periods and PB occurs more commonly in AS, however still occurs in 
QS and wakefulness (25, 26). 
 
Periodic breathing is extremely common in otherwise well preterm infants with nearly all 
experiencing some PB if monitored over 24 hours (45). The incidence decreases with 
advancing PMA, however it is still seen in >80% of preterm infants when they are at term 
equivalent age (46, 47), and also in term infants to a lesser degree (61%) (46). Periodic 
breathing decreases greatly by 6 months of age (44, 48).  
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Although PB is usually considered non-pathological, it can cause significant oxygen 
desaturation. When a desaturation was defined as a drop in arterial oxygenation measured 
by pulse oximeter (SpO2) to <80% for >4s, two studies found that over 50% of infants that 
exhibited PB had an associated desaturation to this level (45, 49).  Horne et al. studied PB 
in relation to brain tissue oxygenation index (TOI) and found that while for most episodes 
of PB there was no effect on brain TOI, some infants did experience individually 
significant drops in SaO2 and brain TOI (47). 
 
The cause of PB is unknown but it is thought to be due to immaturity of the brainstem or 
an increased sensitivity of peripheral chemoreceptors (21, 28). It is self-resolving and no 
treatment is indicated, and is not thought to be a precursor to significant apnoea (22, 28, 
43, 44).  
iii. Apnoea of prematurity  
Apnoea of prematurity is the diagnostic label applied to infants born less than 37 weeks 
GA that experience repetitive apnoea that is deemed clinically significant. It is a 
consequence of physiological immaturity rather than an underlying pathology and 
therefore the many other pathologies (see 2.2.2 iv) that can cause or contribute to apnoea 
must be ruled out before a diagnosis of AOP can be made. Although again contentious, the 
common definition for apnoea used in this setting is a pause in breathing ≥20 seconds, or 
less if associated with a significant bradycardia or desaturation. ‘Apnoea’ of prematurity is 
misleading, as often short, respiratory pauses result in clinically significant bradycardia or 
oxygen desaturation with no consensus on the degree of desaturation or bradycardia 
required before it is considered to be ‘significant’. 
 
Apnoea of prematurity is an extremely common diagnosis in preterm infants. Its 
prevalence is inversely related to GA and it is found in over 50% of all preterm infants and 
almost all those with a birth weight <1000g (50). It usually resolves by 37-40 weeks PMA, 
but can continue past term corrected age up to 44 weeks in very preterm infants (51, 52).  
 
The pathogenesis of AOP is still not well understood. Normal infant respiration physiology 





Table 2-2 Likely physiological contributors to AOP 
Immature central and peripheral nervous system chemoreceptors 
Reduced hypercapnic response (not only preterm infants less than term, infants with 
apnoea less than infants without apnoea)  
Repetitive hypoxic events may increase sensitivity of peripheral chemoreceptors and 
therefore lead to more unstable control and more apnoea  
Hypoxic ventilator depression (from the biphasic curve) 
Infants are very close to pCO2 threshold for apnoea 
Functional obstruction of upper airway due to decreased tone in preterm infants 
Exaggerated response of the laryngeal chemo reflex 
Impaired pulmonary function due to small lung volumes and reduced muscle 
Predomination of active sleep in preterm infants 
 
	
More recent research has implicated the role of genetics in AOP (24). Gaultier et el. 
reported de novo mutations in congenital central hypoventilation syndrome (CCHS) which 
implicates the role of genetics in AOP (53). Bloch-Salisbury et al. published a 
retrospective twin study that report the heritability of AOP amongst same gender twins was 
87% (54).  
iv. Clinical conditions associated with apnoea in preterm infants 
As discussed, AOP is a diagnosis of exclusion. A number of clinical conditions can be 
associated with increasing apnoeic events such as infection, NEC, intracranial abnormality 
or haemorrhage, anaemia, metabolic disorders, sedatives, and thermal instability (28). 
Obstructive apnoea can be caused by congenital malformations such as Pierre Robin 
sequence. There was previously thought to be a link between apnoea and SUDI, but more 
recent research has clarified that there is no link between central apnoea and risk of SUDI, 
however there is an increased risk with mild obstructive apnoea as well as preterm infants 
being at increased risk of SUDI. Screening infants for apnoea at discharge with 






2.2.3 Intermittent Hypoxia  
Intermittent hypoxia (IH) is the term used to describe the episodic drops in oxygen 
saturation and subsequent re-oxygenation that result from recurrent apnoea/AOP. Oxygen 
desaturations can occur as a result of a respiratory pause, while feeding, or in association 
with an arousal from sleep.  They are often not apparent clinically as the duration of the 
desaturation may be too short to result in apparent cyanosis. The prevalence of IH in 
preterm infants is becoming increasingly recognised, as new SpO2 monitoring technology 
with extended memory storage and short two second averaging times can now accurately 
document these events. 
	
Yet again, there is no set definition for what constitutes a pathological desaturation, but a 
fall to less than 90% or 85% SpO2 for ≥3 or ≥5 seconds is common (13). Di Fore et al. used 
the definition of ≤80% for ≥10 seconds and recorded SpO2 for eight weeks continuously 
for 79 preterm infants 24 to 28 weeks GA. They report the incidence of IH increased from 
one to four weeks postnatal age, and then steadily decreased. At the peak of four weeks 
postnatal age, these infants were having an average of 90 episodes of desaturation per day 
based on this definition (59). 
	
Studies in animals have shown that IH, compared with sustained hypoxia is pro 
inflammatory which could have adverse effects on cardiovascular function, growth, ROP, 
and neurological function (60). Studies have also suggested that pro-inflammatory stimuli 
inhibit central respiratory output, meaning that if IH increased pro-inflammatory 
mechanisms, these will in themselves reduce respiratory function, further increasing pro 
inflammatory processes and creating an ongoing worsening cycle for IH (60). 
 
Research in this area is limited as the extent of IH in preterm infants is just becoming 
recognised as new technology that can detect it is developed. It is this phenomenon of IH 









2.3 Cardiorespiratory monitoring in the neonatal unit 
2.3.1 Continuous cardiorespiratory monitoring in neonatal unit  
Monitoring infant cardiorespiratory status is important in order to be able to identify any 
apnoea, oxygen desaturation or bradycardia and therefore the potential need for additional 
respiratory support. This is particularly important in NICU where, as discussed, infants 
commonly have apnoea and oxygen desaturation. 
 
Preterm infants admitted to NICU are monitored continuously from birth until they are 
considered to be free from significant respiratory pauses and are maintaining an adequate 
baseline SpO2. The three main continuously measured cardiorespiratory variables are 
electrocardiogram (ECG), breathing movement, and oxygen saturation. Technological 
advancements mean clinicians no longer have to rely on observation alone (e.g the infant 
becoming cyanosed) to recognise respiratory events in infants; rather the continuous 
monitoring is set to alarm at certain user defined limits, which can alert carers that the 
infant may be in difficulty. The type and quantity of respiratory events that are recognised 
in NICU depends on the specific alarm limits that are set, and how the alarms are 
responded to.  These variables are user set and are therefore often inconsistent between 
units.  
i. Monitoring of breathing movement  
In NICU, breathing movement is most commonly monitored by impedance monitoring, 
where leads are placed on the infant chest (one above and below the diaphragm). As well 
as measuring ECG signals, the leads use electrical impedance to measure changes in lung 
volume and provide a trace of breathing movements. Impedance monitoring can 
distinguish between normal breathing patterns and central apnoea, but cannot accurately 
distinguish obstructive apnoea or measure tidal volume (61). There are other ways of 
monitoring breathing movement that are sometimes used, such as apnoea mats and flow 
sensing devices (e.g nasal flow cannulas).  
ii. Oxygenation monitoring 
It is important to be able to accurately estimate SaO2 levels in preterm infants. The most 
accurate way to do this is by arterial blood samples, through an indwelling umbilical or 
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peripheral arterial catheter. However, this is very invasive and only practical when a 
preterm infant is very young or unstable with a current indwelling catheter. When there is 
no indwelling catheter, arterial blood gases are limited to spot checks of blood gases, 
which again is invasive. Therefore, more commonly, less invasive methods are used to 
estimate SaO2 readings such as pulse oximetry. This enables continuous oxygen saturation 
monitoring to be performed.  
 
Continuous monitoring needs to be non-invasive yet accurate. The mainstay of continuous 
oxygen saturation monitoring in the NICU currently is pulse oximetry. As this is the 
method used in this research, this will be discussed in detail below. Other non-invasive 
methods that are occasionally used include transcutaneous oxygen and carbon dioxide 
monitoring, where an electrode that is separated from the skin by a semipermeable 
membrane heats the skin to provide partial pressure of oxygen measurements. 
Disadvantages of this are the need for regular repositioning and re-calibration.  The use of 
these devices has essentially been superseded by pulse oximetry. 
2.3.2 Monitoring of infants when weaning off supplemental oxygen 
An important time for an infant to be closely monitored in NICU is when they are being 
weaned off supplementary oxygen. This is generally due to the infant having CLD, which 
has meant the infant has been on supplemental oxygen for a long time and they are now 
being weaned to a lower flow rate or completely off supplemental oxygen. Infants will 
often have a 'room air trial' where they are placed off additional oxygen and into room air 
(21% oxygen) and monitored. In Wellington NICU this is done by a continuous pulse 
oximetry recording over a 24-hour period, which is then downloaded and a report printed. 
In Wellington NICU, there are no written guidelines for when a report is considered 
satisfactory enough that the infant can stay off oxygen, but often a threshold of >95% 
mean SpO2 and <5% of time spent at <90% SpO2 is used to determine a 'pass' of this test.  
2.3.3 Monitoring of infants for discharge planning  
Before a preterm infant can be discharged home from the neonatal unit they need to be 
able to take all their feeds orally and gain weight, maintain adequate body temperature, and 
be physiologically stable from a cardiorespiratory perspective. There are various ways to 
assess an infant for cardiorespiratory stability before discharge including: documenting an 
'apnoea free period' while the infant is on impedance monitoring or oximetry monitoring 
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alone, a car seat challenge, 24-hour pulse oximetry, or general overall clinical assessment. 
In Wellington NICU, current practice is to monitor an infant for five days after 
discontinuing caffeine, and if no significant apnoea are documented, they are deemed to be 
stable from a cardiorespiratory perspective. As previously discussed, the AAP 
recommends an infant can be considered for discharge if they are 'physiologically mature 
and stable cardiorespiratory function has been documented for a sufficient duration', 
however no details on how to assess this are specified (8).  
i. Apnoea free period 
Perhaps most frequently used is what is known as an 'apnoea free period', where an infant 
must be determined to be free of apnoea for a certain number of days before being 
discharged. Darnall et al. showed that guidelines for the required number of 'apnoea free 
days' vary across centres from one to ten days, most commonly five to seven days (62). 
They attempted to define a minimal safe apnoea free period and established that apnoea 
(defined in this study as a pause in breathing of >20seconds, or a shorter pause in breathing 
if accompanied by bradycardia or colour change) may occur up to 8 days apart, suggesting 
that the generally accepted five to seven day period may be too short (62). Oxygen 
saturation is not always monitored at this stage and if breathing movement monitors alone 
are used to record apnoeic events, obstructive apnoea is not detected. Nurses usually 
document apnoea by recording when the monitor alarms; however, studies have shown that 
using nurse observation alone to document apnoea is unreliable and can miss many events 
(63, 64).  It would appear therefore that this frequently used method for assessment of 
cardiorespiratory stability pre-discharge has no clear evidence base and may overlook 
potentially significant pauses in breathing less than 20 seconds and persistent IH.  
ii. Car seat challenge 
Pre-discharge 'car seat challenges' are also common when assessing a preterm infant for 
discharge from the neonatal unit. Continuous oxygen saturation monitoring (oximetry) is 
performed for one to two hours while the infant is seated in a car seat to assess their 
cardiorespiratory stability. The length of time the infant is monitored varies from 30 to 120 
minutes. Studies have shown that 12-24 hour polysomnography (PSG), which includes 
oximetry, identifies a greater number of infants with clinically concerning events such as 
apnoea and desaturations than the car seat challenge does, indicating the car seat challenge 
may give false reassurances of an infant's cardiorespiratory stability (65, 66). It has been 
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suggested that reasons for this could be the length of the study (24 hours vs one to two 
hours) and being able to always capture both sleep and wake states in the 24-hour study. 
These studies suggest that 24-hour oximetry monitoring may be of more value than the 
above methods as a pre-discharge tool for assessing cardiorespiratory stability. 
iii. 24-hour pulse oximetry 
Extended (six to 24 hour) pulse oximetry recordings are becoming more frequently utilised 
worldwide, and are sometimes used to assess a preterm infant's readiness for discharge. In 
Wellington NICU, only infants where there is clinical concern about apnoea near the time 
of discharge would be considered for a 24-hour pulse oximetry recording.  
2.3.4 Pulse oximetry  
i Technology 
Pulse oximetry is a non-invasive technique that uses the detection of pulsatile blood flow 
and the differing absorption spectra of oxy-haemoglobin and deoxy-haemoglobin to 
calculate SpO2. SpO2 is the estimate of arterial haemoglobin oxygen saturation (SaO2) by a 
pulse oximeter. Two light emitting diodes (LED) which transmit red and infrared light are 
placed on one side of an infant’s foot or hand, or an adult’s finger, and a photoreceptor 
sensor is placed 5 – 10mm away, directly opposite the LEDs. As deoxy-haemoglobin 
absorbs much more red light and oxy-haemoglobin absorbs more infrared light, the ratios 




Figure 2-1 Pulse oximetry (Pal Oyvind 2012)(67) 
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ii. Limitations 
Pulse oximetry is generally considered to give accurate estimates of SaO2. There are certain 
conditions that can affect the accuracy of pulse oximeters; these are listed in table 2-3. 
	
	
Table 2-3 Sources of inaccuracy when using pulse oximeters 
Limitation Bias 
Poor perfusion Lower SpO2 readings 
Hypothermia Lower SpO2 readings 
Motion artefact Lower SpO2 readings 
Fetal/other types of Hb Lower/higher depending on Hb 
Inaccurate stored 'normal' data Lower/higher depending on data 
Light interference/skin pigmentation Lower SpO2 readings 
 
Pulse oximetry relies on detecting only pulsatile blood flow in order to estimate arterial 
rather than venous oxygenation, therefore background noise from other motion creates 
noise and artefact. Newer pulse oximeters such as the Masimo; (Masimo corporation, 
Irvine, California) have signal extraction technology (SET) designed to reduce this 
artefact. The other main limitation of pulse oximeters is that they rely on algorithms to 
calculate SpO2 that are derived from 'normal' volunteers. Each brand of pulse oximetry 
generally uses their own set of stored data, and therefore there may be inconsistencies 
between oximeters. The accuracy of SpO2 decreases with decreasing SpO2, as normal data 
for SpO2 at low oxygen saturations are limited because it is unsafe to subject normal 
volunteers to such low oxygen levels. Bilirubin does not affect SpO2 as it is a different 
spectrum of light, however dark skin has in some cases been thought to influence SpO2 
(68). 
iii. Measures reported from recordings of pulse oximetry monitoring 
Data from pulse oximetry monitoring can now be recorded and saved and reports 
generated from the data to be interpreted by clinicians. There are many programmes that 
can download this saved data and generate a variety of reports which include different 
measures. In NZ and Australia, the main software package used is PROFOX Associates, 
Inc (69). In this software a variety of measures are calculated and reported, and different 
data reports can be chosen before printing out a summary of the data collected. Examples 
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of such reports are included in Appendix A. Common measures that software packages 
report are mean SpO2, time spent below certain SpO2 values e.g. < 90%, <85% etc, heart 
rate, and number of desaturation 'events', which vary in definition, e.g ≤ 80% for ≥ 4 
seconds. The desaturation index (DSI) is a measure of desaturations per hour, for example 
DSI 4% is the average number of desaturations of at least 4% SpO2 per hour. Lee et al 
suggests that the variability of oxygen saturation measured by the standard deviation (SD), 
which is reported in PRFOX for each patient, is a more useful measure when compared to 
mean SpO2 for predicting oxygen saturation instability in premature infants (70).  
iv. Use of pulse oximetry in paediatrics 
Pulse oximetry is commonly used in NICU as a way of continuously monitoring oxygen 
saturation in infants, assessing infants during oxygen weaning, and sometimes for 
discharge planning. Other uses for pulse oximetry in the paediatric population include use 
when assessing a newborn during resuscitation in the delivery room, as a screening 
procedure to assess severity of obstructive sleep apnoea (OSA) in children, and a screening 
tool for critical congenital heart disease (CCHD). The use of pulse oximetry as a screening 
tool for CCHD in newborns is now validated, although as yet there is no mandated national 
screening program in New Zealand (71). The screening test for CCHD is performed >24 
hours after an infant is born but prior to going home and involves a spot check (connected 
until the perfusion signal is adequate and a reading can be taken, approximately 1 minute) 
of both pre and post ductal oxygen saturations. The AAP guidelines recommend that a 
screen be considered negative if pulse oximetry is ≥ 95% in right hand or either foot with ≤ 
3% absolute difference in oxygen saturation between right hand and foot (72). This type of 
screening does not monitor the infant continuously over an extended period of time and 
therefore only assesses mean SpO2 rather than assessing IH.  
v. Current oximetry guidelines for extended recordings in infants 
Oximeters and their analysis software are advancing in technology. Despite this there are 
no clear guidelines on performing these recordings, nor on how to analyse and interpret the 
data they generate. In NZ there are guidelines from Auckland's Starship hospital from 2009 
on performing and interpreting paediatric oximetry. They provide clear guidance on which 
settings are best, including recommending a short averaging time of two to four seconds 
and recording time more than six hours. However, the indications and data interpretation 
are specific to diagnosing sleep problems in children, and do not mention pre-discharge 
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oximetry for preterm infants (73). The 2009 British thoracic society guidelines are specific 
to the issue of when home supplemental oxygen is needed for infants (74). They 
recommend that if an infant has a mean SpO2  >93%, time spent <90% of <5% and 
desaturations are 'not frequent or excessive' then there is no need for supplemental oxygen. 
These guidelines are based on limited evidence, and more information is needed to be able 
to accurately define 'frequent or excessive' desaturations, as the available guidelines are 
insufficient.  
vi. Extended oximetry in preterm infants: normal values 
There is some available literature on normal values for a range of different infant 
populations such as: oxygen saturation values for the first 24-hours after birth, spot checks 
for term infants at 24 to 48 hours of age, normal oxygenation at different altitudes, and 
oxygen saturations at different ages through childhood (75-79). As this thesis will report 
measures from 24-hour oximetry at discharge in preterm infants, the review of this 
literature is focussed on this age group. Table 2-4 and 2-5 summarise all studies to our 
knowledge that report on normal values for pre-discharge, extended (more than six hours) 
oximetry in preterm infants
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Table 2-5 Normal values for preterm neonatal oximetry 
Author (year) Mean SpO2 Time spent <90% 
SpO2 
Time spent <85% 
SpO2 
DSI 4% Number of. desats < 
80% 
No. Desats < 90% HR Other oximetry measures 
reported 
Rath et al. 
(2015) (80) 
Median: 97 Median (IQR) 3 (1-
14.5) 
Not reported Not reported Not reported Not reported Not 
reported 
Not reported 
Rhein et al. 
(2014) (81) 
Not reported Seconds per hour, 
Mean (SD) 
 
35PMA 106.3 (89) 
36PMA 100.1 
(114.6) 
37PMA 66.8 (75.2) 
38PMA 66 (74.8) 
39PMA 46.4 (47) 
Seconds per hour, 
Mean (SD) 
 
35PMA 46.2 (49.9) 
36PMA 46.1 (66.4) 
37PMA 28.7 (38.6) 
38PMA 27.2 (37.7) 
39PMA 17.2 (21.0) 
Not reported Not reported ≥ 5 seconds and 
deviated from 
baseline ≥ 5%.  
No. per hour, 
mean 
35PMA 8.4 (8.4) 
36PMA 8.2 (11.5) 
37PMA 5.2 (6.8) 
38PMA 4.7 (6.1) 
39PMA 3 (3.3) 
Not 
reported 
Time spent <80% SpO2S-
1 hour, Mean (SD) 
 
35PMA 20.3 (27.9) 
36PMA 21.3 (36.9) 
37PMA 12.6 (19.7) 
38PMA 12.3 (21.5) 
39PMA 6.8 (11.0) 
Shah et al. 
(2014) (6) 




Total mins (in 6 hs 
recording) 
Mean 25 (18) 
Median 20 (4-80) 
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Mean 3.2 % (3.3) 
Median 2.2% (0-
14.6)  
Not reported Events that were 
>10s & <3 min, 
per h of 
recording 
 
Mean 11.8 (8.1) 
Median 10.2 
(0.3-31.5) 
Not reported Not reported Not 
reported 
 SpO2 infant spent 5 & 
10% of time below 
 % time below 91-95% 














al. (2011) (84) 
Median 95 
(92-99) 
Median 4% (no 
range given) 




curves for time spent 
below each SpO2 
Beresford et 
al. (2005) (85) 
Not reported Not reported Not reported Not reported Not reported Not reported Not 
reported 
Cumulative frequency 
curves for time spent at 
each SpO2 




Not reported Not reported Not reported Not reported Not reported Not 
reported 
Cumulative frequency 
curves for time spent at 
each SpO2 
Richard et al. 
(1993) (87) 
Median 99.4 
(90.7 - 100) 
Not reported Not reported Not reported Episodes ≥ 4 seconds 
 
Found in only 18% 
of infants 




Spear et al. 
(1992) (88) 
Not reported Total seconds (6 
hours recording 
time) 
Mean 93.1 (122.7)  
Not reported Not reported ≥6secs, Total 
seconds (6 hours 
recording time) 
 
Mean 7.41 (no SD) 
≥6secs, total 
seconds (6 hours 
recording time) 
 
Mean 15.1 (18.33)  
Not 
reported 
Brady > 5 seconds (n) 
 




Not reported Not reported Not reported No. per hour 
No minimum time 
Median 5.4 (0-156.5)  
 
≥4 seconds 
Median in the 68% of 
infants that had at 
least one episode  
0.2 (0-92.4)  
Not reported Not 
reported 
 Mean duration of 
desaturation 
 Duration of longest 
desaturation 
All median (range) and mean (SD) unless stated 
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Table 2-4 illustrates the large variation in how studies were performed. This makes it 
difficult to compare any of the results from studies, presented in table 2-5. Each study had 
different exclusion criteria, ranging from no exclusion criteria to excluding any infant that 
had any form of respiratory resuscitation at birth. The GA of the infants in each study also 
varied, from including only very premature infants <31 weeks GA, to only late preterm 
infants with a GA of 35-36 weeks, or including all preterm infants <37 weeks. Other 
important features of oximetry recording that can effect the results are the type of oximeter 
used, averaging time, sampling rate, and how artefact was edited. These factors varied 
significantly between studies. The type of oximeter used influences the values produced, 
and as Masimo oximeters are now the main oximeter used in the NICU, the four studies 
that use new Masimo oximeters are most relevant (69, 70, 80, 81, 83). Six of the twelve 
studies reported a short averaging time of less than four seconds; the other six studies did 
not describe the averaging time used so it is difficult to interpret the reported 'number of 
desaturations' in these studies, as different averaging times have different effects on the 
overall results. There were only three studies that performed the pulse oximetry recordings  
'at discharge', and again they had different exclusion and GA criteria (80, 83, 89).  
 
Table 2-5 lists the average values of the oximetry measures that were reported from each 
study. There is a large variation in which measures are reported, and which definitions of 
‘desaturation’ are used, which is problematic when trying to compare studies. There were 
four studies that used new technology Masimo (Masimo Corp., Irvine, CA, USA) 
oximeters (70, 81, 83). Even though two of these studies are comparable in the way they 
were conducted (both studied infants with a GA <32 weeks, who had no recent 
supplemental O2 use and had oximetry at a PMA of 37 weeks) none of the reported 
measures are the same (81, 83). The mean SpO2 is reported in 8/12 studies and varies from 
95.3-99%, and median SpO2 95-99.4%, with no clear pattern between studies that included 
very preterm compared to late preterm infants. The second most frequently reported 
measure was time spent <90% SpO2. The mean reported was 3.2 % and 6.9% (2 studies (6, 
83)), median 2.2 - 5.6% (4 studies (6, 80, 83, 84)) Two studies reported the mean time 
spent at <90% SpO2 over the total recording (6 hours) which was 1.5 minutes in one study 
and 25 minutes in another, which is a large difference (6, 88).  
 
The four studies that compared preterm infants with a control group of term infants 
consistently found significant differences between the groups (6, 80, 83, 85, 89). Shah et 
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al. reported a significant difference in percentage time with SpO2 <90% between late-
preterm infants (7%) and term infants (4%) p = 0.002 (6). Rhein et al. found that while 
mean SpO2 and time spent below 90% SpO2 were comparable between the two groups, 
DSI 4% (events/h) differed significantly (preterm 11.8  ± 8.1 and term 9.6 ± 5.4  p = 
0.0001) (83).  
 
Poets et al. performed oximetry on preterm infants at discharge and again six weeks later 
and reported that the median (range) number of oxygen desaturation to ≤80% SpO2 for ≥4 
seconds per recording decreased significantly, from 3 (0-355) to 0 (0-17) p <0.0001 (90) 
 
In summary, studies that report normal preterm infant extended oximetry values vary 
widely in the way they are performed, making them difficult to compare. There is a lack of 
recent studies using new technology Masimo oximeters. There is also a lack of studies that 
perform the oximetry recordings at the time of discharge from NICU. Research is needed 
in this area to be able to generate normal values so that reports generated from pre-
discharge oximetry recordings have reference values to compare with.  
	
	
2.4 Consequences of respiratory events in preterm infants 
Previous sections have discussed the physiology, monitoring, and current knowledge of 
normative values for respiratory events in preterm infants. A clinician’s decision on the 
level of monitoring required, extent of medical treatment needed, and when an infant can 
be considered ‘stable’ for discharge from a cardiorespiratory perspective depends 
fundamentally on knowledge about the quantity and severity of respiratory events that can 
be tolerated without causing any short or long term adverse consequences. In particular, 
knowledge about the accepted parameters that define the length of pause in breathing, level 
of oxygen desaturation, and amount of intermittent hypoxia, that is no longer considered 
normal respiratory variability but pathological and of possible clinical significance, is 
necessary for clinical decision-making.   
	
It is biologically plausible that frequent pauses in breathing and the subsequent possible 
oxygen desaturations may cause damage to the developing brain, and therefore have long 
term consequences on development and growth. Serious morbidity can be associated with 
hypoxic – ischemic encephalopathy (HIE). This clinical presentation occurs when there 
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has been a significant period of cerebral hypo-perfusion associated with low oxygen 
saturations in relation to an asphyxia event during the perinatal period. The likelihood of 
brain damage and long-term disability after such an event depends on the severity of the 
event. Respiratory pauses and bradycardia in preterm infants have been demonstrated to 
cause cerebral hypo-perfusion and a decrease in cerebral oxygenation (91-93). Within a 
respiratory event, simultaneous bradycardia and hypoxaemia cause the greatest decrease in 
cerebral oxygenation, compared to either occurring alone (94). Periodic breathing, which is 
generally thought to be benign and to cause no long term consequence, has also been 
shown to cause cyclic deoxygenation and reoxygenation of cerebral blood flow (95, 96).  
	
Apnoea and IH are commonly seen and even considered ‘normal’ in preterm infants, 
however we must remember that preterm infants are in fact not ‘normal’, in the sense that 
they have been brought into this world prior to when they were intended to be born and 
this premature birth has been for a variety of clinically significant reasons. These events 
that may be considered ‘normal ‘in preterm infants may still have detrimental effects on 
the developing infant brain and research into this area is therefore crucial.  
	
The following section will discuss current knowledge on adverse outcomes associated with 
apnoea during infancy (in term and preterm infants), knowledge on the association 
between recurrent apnoea and growth, oxygen saturation targets in the NICU, and finally 
adverse effects of intermittent hypoxia in particular.  
2.4.1 Consequences of apnoea in full term and preterm infants 
Research has focused on outcomes of cardiorespiratory events and apnoea during infancy, 
which, as discussed in section 2.2.2 is not consistently defined, however is often described 
as a pause in breathing for more than 20 s. Most literature focuses on the effect of these 
respiratory events on neurodevelopmental outcomes, often using the Bayley Scales of 
Infant Development or The Griffiths Mental Development Scales, in combination with a 
neurological assessment by a paediatrician. 
i. Full term infants 
Black et al. published a paper in 1979 that suggested that increased respiratory instability 
in full term infants negatively impacted on neurodevelopment (97). They assessed 122 full 
term, healthy infants using a one hour nap polygram recording during their first week of 
life and again at four weeks of age. The relative frequency and average duration of apnoea 
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were used to develop a score of respiratory instability. Infants with increased respiratory 
instability in their first week of life, averaged significantly lower in both mental and 
psychomotor development on the Bayley scale at nine months of age (p < 0.0001); 
furthermore, infants with increased respiratory instability at four weeks scored even lower 
on the Bayley scale.  
	
Consequent studies during the 1980’s investigated full term infants with reported apnoea 
as an infant and found that there were no differences in their neurodevelopmental 
outcomes (IQ, behaviour scores, neurological assessment) when compared to controls (98, 
99). The only significant finding (in a small study of 14 apnoeic infants) was impairment 
in gross motor scores when compared to siblings (98). The small numbers in the study may 
have affected the study outcomes. Timing of neurodevelopmental testing in these studies 
ranged from two to ten years of age, which is another limitation of the study. 
ii. Preterm Infants  
Tudehope et al. published a paper in 1986 that followed very low birth weight (VLBW) 
infants and similarly reported that after adjusting for confounders (Low birth weight, need 
for assisted ventilation and presence of CLD), apnoea (defined as a pause for >10 s) was 
not a predictor for adverse neurodevelopmental outcomes as assessed by the Griffiths scale 
at 2 years of age (100).  
	
Another study published in 1993 studied 60 premature infants with ‘AOP’, defined as an 
apnoea or bradycardia requiring stimulation by a nurse, confirmed by an abnormal 12-hour 
pneumocardiogram (abnormal defined as an apnoea lasting > 20 s or PB for >5% total 
recording time or a bradycardia to less than two thirds of resting heart rate (HR) for >10 s) 
(101). These infants were matched for GA and severity of neonatal illness to controls and 
both underwent neurodevelopmental testing at 12-24 months. Again, there were no 
significant differences in neurodevelopmental outcomes (Bayley mental and motor scores) 
between groups. The only difference seen was a greater number of infants with AOP in the 
‘mild motor delay’ range compared to controls. 
	
These earlier studies suggest that after correcting for GA and neonatal morbidity, there are 
no significant adverse neurodevelopmental outcomes for infants that experience apnoea. 
More recent studies however have suggested that apnoea during early infancy in preterm 
infants is associated with adverse outcomes. Two large studies looked at the ability of ‘pre-
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discharge’ 24-hour monitoring (using 4 channel pneumograms) of preterm/VLBW infants 
to predict adverse outcomes post-discharge (102, 103). Cheung et al. used mean 
bradycardia, mean oxygen desaturation and frequency of ‘apnoea’ (defined as >12 seconds 
with associated desaturation or bradycardia) as their pre-discharge measures and assessed 
infant neurodevelopment at 2 and 3 years of age. They found that the pre-discharge study 
was an independent predictor in the high risk group of infants (IVH grade 3 or 4) of the 
Bayley mental and motor scores at 2 years of age, however infants in the low risk group 
(no IVH or IVH grade II or III only) showed no association.  They concluded that pre-
discharge respiratory recording is a useful tool to predict neurodevelopmental outcomes for 
high-risk VLBW infants (103). Subhani et al. defined a ‘normal’ pre-discharge recording 
as one where there were no apnoea for > 20 s or no HR to <80bpm for >5 s. The abnormal 
group was compared with the normal group for rates of apnoea related hospital 
readmission, apparent life threatening events (ALTE) or death. Four of the abnormal group 
(n=32) had post-discharge complications whereas none of the 74 in the normal group had 
any of the documented post-discharge events. The two groups were of no difference in 
terms of GA or severity of neonatal course. This research suggested that a ‘normal’ pre-
discharge respiratory recording can predict infants with a low risk of serious adverse 
outcomes (102).  
	
In three recently published studies, researchers recruited preterm infants and used 
frequency of apnoea during NICU stay as a measure of exposure to respiratory instability. 
Nurse documentation of machine alarms was used to define frequency of apnoea in all 
studies (104-106). All three studies report that increased frequency of apnoea during the 
NICU stay is associated with worse neurodevelopmental outcomes. Janvier et al. studied 
175 preterm infants (< 32 weeks GA or <1250g BW) and recorded number of days during 
hospitalisation that the infant had a least one nurse documented ‘apnoea’ (machines 
normally set to alarm < 84% SpO2 or <100bpm).  They assessed infant neurodevelopment 
at three years of age and found that, after correcting for multiple factors (IVH/GA/use of 
antenatal steroids), the total number of apnoea days was significantly associated with 
neurodevelopmental impairment (defined as a Bayleys mental/psychomotor developmental 
index (MDI/PDI) <70), CP or blindness)(104). Pillekamp et al. studied the frequency of 
apnoea during the NICU stay of 83 VLBW infants (Machines alarmed at <86% SpO2 or 
<80bpm (for infants <35wks GA) or  <100bpm (infants >35wks GA), and also 
documented the severity of each apnoea. They found that after correcting for GA, only the 
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‘adjusted daily apnoea score’ (calculated as frequency of apnoea multiplied by severity) 
from 31-37 weeks PMA was predictive of neurodevelopmental outcomes at 13 months of 
age (<69 MDI/PDI) (105). Greene et al. studied 98 infants <1000g BW and again used 
nurse documentation of ‘cardiorespiratory events’ (CRE), which were defined simply as a 
HR <80bpm. They reported that more frequent CRE was associated with worse language 
scores on the Bayley III at 8 months (P < 0.05), and more severe CRE (measured by lowest 
HR during each event) was associated with receptive language delay at 20 months (106).  
iii. Comparing preterm with term infants 
The Collaborative Home Infant Monitoring Evaluation (CHIME) is one of the largest 
studies looking at cardiorespiratory events on home monitors. This large study consisted of 
1079 infants including; healthy full term infants, infants with a history of ALTE, infants 
with a history of sudden infant death syndrome (SIDS) in a sibling and preterm infants ≤ 
34 weeks and BW <1750g.  The CHIME study included 256 infants (138 full term and 118 
preterm) that also completed neurodevelopmental testing at one year of age. For this study 
published in 2004, infants were classed as having 0, 1-4 or 5+ events over the 180 days of 
home monitoring (minimum of 175 hours total recording)(107). Events were defined as an 
apnoea > 20 s or HR <60bpm for at least 5 s or <80bpm for at least 15 s if aged  >44 weeks 
PMA. They reported that both term and preterm infants in the 5+ events group had lower 
mental (MDI) and motor (PDI) Bayleys scores when compared with the 0 events group; 
however, after adjusting for confounders, only MDI was significantly different (p = 0.03 
term infants, p = 0.04 preterm infants).  
iv. Summary 
From the studies reviewed, current evidence on the consequences of apnoea is conflicting. 
Some studies report no association between the presence of recurrent neonatal apnoea and 
adverse developmental outcomes (98, 99), or report associations that disappear after 
controlling for confounders (100, 101, 107). Some report an association only in already 
high-risk infants (103), and some studies do report that neonatal apnoea is an independent 
predictor of adverse consequences (97, 102, 104-107). 
	
When considering adverse outcomes associated with ‘apnoea’ in preterm infants, possible 
confounders need to be considered. Poor neurodevelopment and more frequent apnoea are 
both independently correlated with many primary sources, such as GA, IVH, or other brain 
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insults in the early neonatal period. Therefore, it may be that apnoea is purely a marker of a 
more severe neonatal course or brain injury, which in itself leads to worse 
neurodevelopmental outcomes. Intervention studies are needed to establish whether a 
decrease in apnoea causes an improvement in outcomes, which would determine whether 
treatment of the respiratory instability would be indicated.  
	
Most studies simply compared infants with apnoea to infants without, with the definitions 
of apnoea varying, which results in inconsistent definition of an already crude exposure, 
and does not focus on the differing severity or duration of the events. Studies also often 
used the non-objective measure of nurse documentation to assess apnoea prevalence, rather 
than analysis of data from continuous monitoring. Nurse documentation has been shown to 
be unreliable (108). Studies commonly used length of a respiratory pause to identify 
infants with worse apnoea, rather than focusing on the consequence (and likely 
pathological component) of the respiratory pause, such as a decreased heart rate or degree 
of oxygen desaturation.  No study used measures such as a desaturation index (DSI), which 
would identify the frequency of intermittent hypoxia, quantifying exactly how much 
respiratory variability there is rather than simply looking at infants with ‘apnoea’ or no 
apnoea. It is possible that with more precise measures, research may start to report a more 
consistent picture of adverse outcome associated with respiratory instability. The current 
study uses continuous oximetry monitoring over 24 hours, with a range of measures of 
intermittent hypoxia reported.  
2.4.2 Association between respiratory stability and growth 
It is known that children with severe OSA have an increased rate of failure to thrive and 
studies consistently report an increase in weight gain velocity for children after surgical 
treatment (tonsillectomy and adenoidectomy) (109-116). Adults with OSA have also been 
shown to gain weight after treatment with CPAP. One large recent (2015) meta-analysis 
that included 25 high quality papers found that there is a significant increase in BMI after 
treatment of OSA with CPAP (117).  
 
The cause of this growth restriction in children and adults with OSA has been suggested to 
be a combination of increased energy expenditure and an imbalance in growth hormones. 
In obstructive respiratory events, there is increased breathing effort, and therefore an 
anticipated increase in energy expenditure. Marcus et al. found that after children had been 
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treated surgically for OSA they did indeed have less energy expenditure during sleep and 
more weight gain compared to before treatment (115). However, Bland et al. reported no 
difference in total energy expenditure (TEE) between children with OSA and controls, and 
found no significant difference in TEE after surgical treatment in the OSA subjects. 
Nieminen et al. reported insulin-like growth factor 1 (IGF-1) secretion is impaired in 
children with OSA, and returns to normal after surgical treatment (113). Bar et al. similarly 
reported an increase in IGF-1 after surgical treatment for OSA in children, suggesting 
growth hormone impairment is an important contributor to the phenomenon of decreased 
weight gain in children with OSA (112).  
 
There have been few studies that evaluate the association between respiratory stability and 
growth in infants, however the few reported studies indicate a positive association (118-
121). Riordan et al. studied 99 healthy full term infants and reported that the presence of 
PB was inversely correlated with percentage weight gain in the first two months of life 
(118). The three studies that do report on growth as an outcome for preterm infants report 
only on those preterm infants with CLD. They report a general decrease in growth for 
infants with CLD and an association between oxygen administration and increased growth 
rates (119-121).  
	
Farahani et al. examined rat pup growth, comparing controls to animals exposed to chronic 
constant hypoxia (CCH), and chronic intermittent hypoxia (CIH) in the first four weeks of 
life (122). They reported a decrease in weight velocity for both CIH and CCH groups 
compared to controls, with the CCH group more severely affected than the CIH group. 
CCH is consistent with CLD (although there would be somewhat less CCH if the infant is 
treated with oxygen), whereas CIH would be more comparable to infants with AOP or PB. 
Pozo et al. also studied growth in rat pups by exposing two groups to different patterns of 
repetitive IH and comparing with a control group (123). They found both IH patterns 
resulted in growth restriction when compared to controls, with pups displaying a catch up 
growth pattern when the IH exposure was stopped.  
	
As can be seen from the animal, child, adult, and limited infant studies discussed, it is 
plausible that increased respiratory instability, including increased respiratory pauses and 
more frequent IH, could be associated with decreased growth rates in preterm infants. The 
likely pathophysiology appears to be a combination of increased energy expenditure and 
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decreased growth hormone production. The exposure to hypoxia itself may be a 
contributory factor. Adequate growth in preterm infants is important, as postnatal weight 
gain in preterm infants is associated with neurodevelopmental outcomes, as reported 
recently in a systematic review (124). Despite this theoretical conclusion, to our 
knowledge there are no published studies that investigate the association between 
increased respiratory instability and growth rates in preterm infants without CLD. The 
current study examined growth rates in the one month post discharge from NICU.  
2.4.3 Oxygen targets in the neonatal unit 
The majority of previous research on oxygenation in preterm infants has been focussed on 
baseline oxygen levels rather than intermittent hypoxia. A number of large multi-centre 
studies have tried to define a ‘safe’ baseline oxygen saturation target for preterm infants 
(125-130). These studies were driven by the realisation that ROP can be caused by 
hyperoxia. Studies are conflicting, but generally report that although there is a lower rate 
of ROP at the target range of a SpO2 of 85-90%, the mortality rate is higher than when 
baseline oxygen saturation targets are 90-95% (125-128). A further study has suggested a 
SpO2 target of 90-95% is preferable to 95-100% (129). It has also been reported that 
infants in the lower target ranges have higher rates of intermittent hypoxia (130). The 
BOOST (Benefits Of Oxygen Saturation Targeting) study was a large study that recruited 
2448 preterm infants from the United Kingdom, Australia and NZ (131). Infants were 
randomised into a 85-89% SpO2 target group or a 91-95% SpO2 target group. The study 
was stopped early as infants in the lower oxygen saturation target group were found to 
have significantly higher mortality rates (23.1% vs 15.9%). Infants in the lower oxygen 
saturation target group had lower rates of ROP but higher rates of NEC. 
2.4.4 Consequences of intermittent hypoxia 
Intermittent hypoxia has been discussed previously in section 2.2.3 and is the most 
important component of a respiratory event, as it is the severity and frequency of oxygen 
desaturation and resaturation that is thought to be harmful, rather than simply the length of 
respiratory pause. Most studies discussed so far require a minimum length of pause to 
classify ‘apnoea’, however even very short pauses, or simply bradycardia, may result in 
hypoxia. Hypoxia can also be associated with movement and arousal from sleep. 
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Studies investigating the specific association between IH and adverse outcomes in preterm 
infants are lacking. However, there are a large number of recent studies looking at the 
consequences of IH in adults with OSA (132-135). These studies suggest that the cyclic 
deoxygenation and reoxygenation that occurs with OSA associated IH induces excessive 
reactive oxygen species (ROS) and activates proinflamatory transcription factors, which 
result in various pathologies; mainly cardiac, neurological, and metabolic dysfunction. 
 
There have also been many rodent studies published that investigate the effect of IH on 
rodent physiology. These studies indicate that exposure to IH can cause cardiorespiratory 
dysfunction and neurodevelopmental delay (136-138), as well as impaired growth. In 
contrast one rodent study reported that mild exposure to IH was in fact neuroprotective 
(139). 
	
Bass et al. conducted a large review of the evidence regarding the effect of chronic and 
intermittent hypoxia on childhood cognition (140). The review included papers that 
reported on clinical conditions associated with chronic hypoxia such as congenital heart 
disease (CHD) and conditions associated with IH, such as sleep disordered breathing 
(SDB). They reported that 31 (83.8%) of the 37 controlled studies that qualified for the 
review reported an adverse effect on childhood cognition. Sleep disordered breathing, 
which is associated with IH, was one of two clinical conditions that after review of the 
evidence, satisfied the Evidence Based Paediatrics and Child Health criteria for causation 
of adverse childhood cognition. Bass et al. also concluded that “Because adverse effects 
have been noted at even mild levels of oxygen desaturation, future research should include 
precisely defined data on exposure to all levels of desaturation”.  
 
Poets et al. published a paper in 2015 that, as part of the Canadian Oxygen Trial (COT) 
study, reported on the association between episodes of hypoxemia (pulse oximeter oxygen 
saturation <80%) or bradycardia (pulse rate <80/min for 10 s or longer) and serious 
morbidity or mortality in preterm infants. They found there was an association between 
prolonged hypoxemia (episodes lasting longer than one minute) and serious morbidity or 
mortality at 18 months (relative risk, 1.66; 95% CI, 1.35-2.05), with no significant 
association for episodes shorter than this (141). A recent review discusses potential 
morbidity caused by IH in preterm infants (60). This review concluded that there is 
evidence that IH is a contributing cause, alongside hyperoxia, of ROP (59) with limited 
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evidence that IH may be contributing to broader outcomes such as growth, cardiovascular 
dysfunction and neurodevelopmental outcomes. The authors called for more research into 
the area. Many other authors also call for research to be focused on the extent of the 
oxygen desaturation and quantity of IH rather than apnoea, and state the need for future 
studies on the effects of IH in preterm infants (24, 45, 142, 143).  
 
With recent advances in technology, including advanced oximetry algorithms and shorter 
averaging times that improve the accuracy of oximeters, the extent to which IH occurs in 
preterm infants is now able to be accurately documented and the magnitude of IH in 
preterm infants is becoming recognised. The current study investigates IH in preterm 
infants and specifically how measures of IH on oximetry, such as DSI, correlate to growth 
in the first month of life post discharge.  
	
	
2.5 Respiratory support and treatment options for apnoea in preterm 
infants 
Preterm infants often require respiratory support at birth and sometimes require continued 
support until they have matured sufficiently to be able to effectively ventilate their own 
lungs and maintain an adequate SaO2, as well as be free from prolonged pauses in 
breathing and oxygen desaturation. Apnoea associated with RDS, a common respiratory 
condition in very premature infants (discussed in section 2.1), is treated by ventilation and 
administration of exogenous surfactant via an endotracheal tube. As well as surfactant 
administration, premature infants often need additional assistance over time such as with 
CPAP, additional inspired oxygen, and drugs such as caffeine. New treatment options for 
apnoea and intermittent hypoxia are also being investigated.  
2.5.1 Current treatment  
i. Assisted Ventilation  
When an infant is born extremely premature (< 26 weeks GA), they may initially have no 
breathing effort at all and require invasive ventilation (intubation with an endotracheal 
tube) in order to mechanically inflate and oxygenate their lungs. These infants are often 
given intermittent positive pressure ventilation (IPPV), which delivers set positive 
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inspiratory and end expiratory pressures (PIP and PEEP), which effectively ventilate the 
infant they cannot initiate or maintain breathing. 
 
Once infants mature and can maintain respiration on their own they can be extubated and 
less invasive measures such as nasal prongs or a nasal mask are used with a continuous 
flow of positive airway pressure (CPAP), which helps to keep the infant's alveoli open, 
ensuring successful oxygenation of their lungs. Non-invasive CPAP ventilation is very 
common in the NICU and is often the only form of assisted ventilation a premature infant 
requires. Some infants only need CPAP support at birth for a few hours while some may 
require CPAP support for a few weeks. In the ANZNN 2013 report, 82% of infants 32-36 
weeks GA required CPAP for at least 4 hours (4). Often CPAP is achieved by the infant 
wearing nasopharyngeal prongs (nasal CPAP); alternatively, a high flow nasal cannula 
(HFNC) that is set at a flow of >2L can also deliver effective respiratory support (145). 
Non-invasive CPAP can be used to treat obstructive and mixed apnoea by splinting the 
upper airway open, but will not always treat central apnoea (where there is no respiratory 
effort) sufficiently (146). 
	
All assisted ventilation options can use either air (21% O2), or a mixture of air and oxygen 
to deliver addition inspired oxygen (>21%O2). For some infants, positive pressure support 
is enough to maintain their SaO2, whereas other infants need additional inspired oxygen to 
maintain SaO2. Because oxygen toxicity has now been recognised, clinicians aim to have 
an infant on the lowest amount of supplemental O2 possible.  
ii. Pharmacotherapy (caffeine) 
Methylxanthines (caffeine/theophylline/aminophylline) are the main treatment used for 
infants with recurring apnoea. They are a non-selective antagonist of adenosine receptors 
and are though to act as a respiratory stimulant by increasing the neural respiratory drive, 
increasing minute ventilation, increasing CO2 sensitivity, as well as increasing the strength 
of diaphragm contractility, however the exact mechanism of how methylxanthines work is 
unknown (147-149). 
	
Caffeine is now the preferred drug over other methylxanthines. Compared to theophylline, 
caffeine is just as effective but has a better safety profile (150). It has a longer half-life, 
meaning it can be given just once a day in preterm infants and it has a higher therapeutic 
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index, therefore less side effects (such as feed intolerance, hyperactivity, and seizures with 
theophylline), and no requirement for monitoring by blood tests. Caffeine can still have 
some side effects however, the most common being tachycardia.  
	
Methylxanthines have been shown to be effective compared to placebo in reducing rates of 
apnoea short-term, as well as lower rates of death and CLD in the short term (up until 
discharge from the NICU (151, 152). The long-term effects of caffeine have also been 
shown to be beneficial. A large multi-centre study: Caffeine therapy for Apnoea of 
Prematurity (CAP); reported on survival and neurodevelopment at 18-21 months for 
preterm infants who were randomised to receive either caffeine or placebo for treatment of 
their AOP while in NICU. In the caffeine group 40.2% of infants died or survived with a 
neurodevelopmental disability compared with 46.2% in the placebo group (OR 0.77, CI 
0.64 to 0.93; p = 0.008) (153). Doyle et al. published a study that randomised very preterm 
infants to receive caffeine or placebo and then analysed magnetic resonance imaging 
(MRI) performed at one year of age. They found no significant differences between the 
groups in the amount of white or gray matter abnormality, or in global or regional brain 
volumes; however, significant differences in diffusion changes were seen that were 
consistent with improved white matter microstructural development in the group that 
received caffeine (154). 
	
Very preterm infants (born <32 weeks GA) are often started on caffeine prophylactically 
soon after birth, while preterm infants born at a later GA may only be started on caffeine if 
they are noticed to be having apnoea that is thought to be clinically significant. Premature 
infants generally continue taking caffeine until they are 34-35 weeks PMA. In Wellington 
NICU, if there are no concerns, an infant would be taken off caffeine at 35 weeks PMA 
and then routinely monitored for an extra five days.  If there are no events documented 
during these five days they will be taken off monitoring and considered stable from a 
respiratory perspective.  
	
Doxapram is a respiratory stimulant and is sometimes used to treat refractory apnoea that 
does not respond to caffeine treatment. There is currently insufficient evidence on its 
efficacy and safety and advice is that it should be used with caution (155). 
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2.5.2 Future directions for treatment of apnoea / IH 
i. Extended use of caffeine 
Rhein et al. investigated the use of extended treatment with caffeine (continued after 
routine discontinuation of caffeine) for preterm infants (81). Infants were randomised into 
a routine care group or extended caffeine group. The incidence of IH (defined as time 
spent <90% SpO2) was significantly lower in the extended caffeine group compared to 
controls until 36 weeks PMA, with no significant differences between groups after infants 
reached 36 weeks PMA. It is suggested the difference in groups was not seen past 36 
weeks GA due to insufficient dosing. This could be due to the study not accounting for the 
changing caffeine citrate half-life, as its half -life has been shown to decrease with 
advancing PMA and so more frequent dosing is required (81, 156). 
ii. Blood transfusions 
Haemoglobin levels in preterm infants can influence the severity of IH in premature infants 
(15, 157). Red blood cell (RBC) transfusions as treatment for apnoea have been considered 
for some time, and results from studies have shown reduced rates of apnoea (157-159).  
Abu Jawdeh et al. published a study in 2014 that accurately recorded IH before and after 
RBC transfusions in premature infants and found that the frequency and severity of IH was 
significantly reduced for up to 48 hours after a RBC transfusion in premature infants more 
than one week old. This study is limited by the short follow up monitoring period of 48 
hours and does not assess the more long-term impact of blood transfusions on IH (160).  
iii. Kinaesthetic treatments 
Physical stimulation is often used to treat individual episodes of apnoea. Other tactile 
stimulation methods such as oscillating waterbeds have ben trialled to reduce the incidence 
of apnoea and IH. There is no good evidence to date on the efficacy of these methods 
(161). Bloch-Salisbury et al. recently reported that the use of stochastic mechanosensory 
stimulation (vibrotactile stimulation from actuators embedded in a mattress) stabilised 
premature infant respiratory patterns, with a significant decrease in incidence of apnoea 







2.6 Preliminary research  
Prior to this study commencing, a pilot study investigating the current use of extended 
oximetry for premature infants at discharge across New Zealand and Australian NICU’s 
was undertaken as a summer student project (69) 
 
The study was performed by creating an online survey on the use of pre-discharge 
oximetry and this was sent to all level three neonatal units in NZ and Australia as well as 
all level two units in NZ (N = 46). A total of 27 units responded (59%).  
 
Considerable variation was found in how preterm infants are screened by oximetry studies 
prior to discharge across Australasia and also in how studies are performed and reported. 
No unit reported routinely performing oximetry at discharge for all preterm infants, and 
one fifth of units surveyed never perform specific oximetry at discharge. The groups of 
infants for which units do undertake pre-discharge oximetry varies, with infants discharged 
on supplemental oxygen the only group routinely receiving pre-discharge oximetry in 
those units using this test. 
 
The most common brand of oximeter used was Masimo® with PROFOX Associates, Inc. 
the most common oximetry analysis software. Most oximetry reports generated appeared 
to be PROFOX Associates, Inc.'s default 'Summary Report', with most units keeping the 
software’s default settings including the default desaturation definition ('a drop in 
saturation by 4 or more'). Only 20% of units surveyed manually removed artefact from 
their recordings. Measures on oximetry reports that quantitate intermittent hypoxia, such as 
number of desaturation events to SpO2 of <95% or number of drops in oxygen saturation 
per hour by 2% or 3% (DSI 2%/3%) were less frequently used compared to mean SpO2 
and time spent <90% SpO2. 
	
This preliminary research study highlighted areas to focus on such as the editing of 
oximetry reports. It reported on which groups of infants neonatal units are currently 
utilising extended oximetry at discharge and also gave insight into which models of 
oximeters are currently being used as well as how units configure their oximeters and edit 






The pathophysiology of apnoea in premature infants is fundamentally an immature 
respiratory central nervous system, combined with immature and suboptimal lung function. 
The clinically concerning part of any ‘apnoea’ or respiratory event is the oxygen 
desaturation rather than the length of the pause, however the degree or frequency of 
oxygen desaturation that should be of clinical concern is unknown. There has been some 
research into the consequences of apnoea in infancy, with limited research into intermittent 
hypoxia specifically; this research does indicate a correlation with neurodevelopmental 
outcomes. There have been no reported studies that investigate the effect of these 
intermittent hypoxic episodes on growth in preterm infants, however theoretically IH may 
cause increased energy expenditure in combination with a decrease in growth factors 
which could effect growth.  Adult and rat studies have also indicated a possible 
association. Pulse oximetry is a safe and effective way of continuously measuring oxygen 
saturations and is now refined with two second averaging times that detect brief drops in 
oxygen saturations. Some neonatal units in Australasia are utilising this tool to assess 
preterm infants in anticipation of discharge, however the way these reports are edited and 
the settings used to perform these recordings varies widely. This current study investigates 
the incidence of IH at discharge in preterm infants and also looks at the effect of IH on 
growth rates post-discharge.  
	
2.8 Aims and hypotheses  
2.8.1 Aims 
This study had two parts, the primary study and a smaller follow up study. For the primary 
study, all preterm infants were recruited to have a 24-hour oximetry recording performed 
just prior to their discharge home from the neonatal unit. The primary aim of this study 
was: 
	
1. To determine normative ranges for measures reported from an ‘at discharge’ 24-
hour oximetry study 
	




1. To determine whether there is a clinical difference in raw, automatically edited,  
and manually edited reports.  
2. To determine whether there is any clinical difference in 12-hour ‘overnight’ 
recordings compared to full 24-hour recordings. 
  
The follow up study included only the very preterm infants (< 32 weeks GA) from the 
primary study group. Its purposes were: 
	
1. To determine whether intermittent hypoxia, measured by measures reported from 
24-hour pre-discharge oximetry recordings (number of  > 4% SpO2 desaturations 
per hour (DSI 4%), DSI 3%, DSI 4% > 10 seconds and time spent <90% SpO2), 
had an impact on infant post-discharge growth as measured by weight Z-scores. 
2. To determine the difference in intermittent hypoxia at one month post-discharge 
compared to prior to discharge. 
	
This was achieved by following these very preterm infants for one month after discharge to 
record weekly growth measurements, and performing a repeat 24-hour oximetry recording 
at home at one-month post discharge.  
2.8.2 Hypotheses  
1. All preterm infants will have high rates of intermittent hypoxia (as measured by 
DSI 3% and DSI 4%) when discharged home from the neonatal unit and infants 
born at an earlier GA or discharged at an earlier CGA would have more severe 
intermittent hypoxia.  
2. Very preterm infants with greater intermittent hypoxia at discharge will have a 
slower rate of growth in the first month post discharge.  
3. Levels of intermittent hypoxia in very preterm infants will have decreased one 





3.1 The use of oximetry to measure oxygen saturation 
3.1.1 Oximetry  
As discussed in the previous chapter, the pathological component of any respiratory pause 
or ‘apnoea’ in preterm infants is likely to be the level of oxygen desaturation, and possibly 
the bradycardia, rather than the length of the pause (60). Low oxygen saturations can occur 
without an accompanying pause in breathing, therefore breathing monitors alone would not 
pick up all events (163). Oxygen saturation monitors (oximeters), are advancing in 
technology and can now accurately record an extended period of monitoring. Their ease of 
use and cost effectiveness compared to a full polysomnography (PSG) means that extended 
oximetry recordings are becoming a more appealing option when assessing paediatric 
respiratory stability. These oximetry recordings produce a report that includes many 
different measures of respiratory instability (see attached examples, appendix A). The 
default report type generated is the ‘summary report’, which is hard to interpret with no 
visual graphs. The ‘comprehensive report’ is only printed if a separate tick box is checked 
and is a simple one page report that summarises the oximetry report as well as having a 
visual graph of time vs SpO2 which is quick to interpret and gives you an overall picture of 
the infant’s oxygen saturations over the recording period. The normative values or 
significance of these more recently accessible measures of respiratory instability are 
largely unknown. For these reasons, we used 24-hour oximetry as our tool to assess an 
infant’s respiratory stability, and to generate normative values for measures on these 
oximetry reports for preterm infants at discharge home from the neonatal unit.  
 3.1.2 MasimoSET technology 
MasimoSET technology has been shown to be more accurate during motion than other 
oximeters, with one study giving MasimoSET a performance index (percentage of time in 
which the SpO2 is within 7% of control value) of 94%, which was the highest of all 20 
oximeters tested, with the next best oximeter being the Agilent Virdia at 84% performance 
index (164). Other studies have confirmed that MasimoSET technology is the most 
accurate during motion (165-168). The accuracy of the Masimo Rad – 8 (used for this 
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study) for SpO2 is reported as ± 3% for neonates for SpO2 values of 70% - 100% and ±4% 
for SpO2 values of 60% - 80% for neonates (169) 
	
The averaging time used for this study was two seconds, which is the standard averaging 
time when set to sleep mode. When not in sleep mode the averaging time is eight seconds. 
It is important to use a short averaging time as longer averaging times may smooth out 
short desaturations and underestimate the level of intermittent hypoxia (170, 171). 
3.2 Dealing with artefact 
3.2.1 The problem of artefact 
Recordings of physiological data will undoubtedly include some artefact. Artefact in 
oximetry recordings is often caused by movement and is difficult to avoid. Editing infant 
oximetry recordings compared to adult recordings is complicated as infant oxygen levels 
can drop quickly (up to 8% per second), partly due to their small pulmonary reserve (49). 
This means that when analysing oximetry traces for infants, what would be considered 
artefact in adults (rapid drops in SaO2) could in fact be true desaturations and the process 
of editing data becomes a lot more time consuming and uncertain. Oximetry SpO2 readings 
are often verified by observing the concurrent pulse waveform, if this is regular then the 
SpO2 reading is taken as correct.  
		
In our study, PROFOX Associates, Inc. software was used to download and report the 24-
hour oximetry study. This is by far the most common software package used in Australasia 
for this purpose (69). This software package does not report a concurrent pulse waveform, 
only pulse and SpO2 traces. When looking at the recordings, there were many sharp 
desaturations and some areas where the recording completely dropped out, which was 
suspicious for artefact. MasimoSET technology states that it is accurate during motion, 
however much of this presumed artefact seen is likely due to movement as it appears to 
often coincide with an infant’s cares. 
 
A sample comparison of one infant’s oximetry report produced three different ways; 
unedited data, automatically edited data by PROFOX, and manually edited data, produced 
some large differences in at least some measures reported. For example percentage time 
spent less than 90% SpO2 was 4.1% unedited, 2.5% when manually edited and 2.2% when 
automatically edited. It was clear that a robust method of editing these data was needed in 
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order to make the data as accurate and consistent between recordings as possible in order 
to confidently define normative values.  
 
There are no guidelines to our knowledge on how to remove artefact from these data and 
when talking to leading NZ paediatric respiratory clinicians, neonatologists, and 
respiratory technicians who look at these oximetry reports frequently, no one could give 
clear advice on how to best edit data, admitting it was mainly guess work, with everyone 
spoken to indicating that guidelines are required. In fact, when surveyed, only 20% of 
neonatal units manually edit their data at all, with only 40% reporting their software 
automatically deletes artefact (69). When assessing the literature, there is also no 







































Software  Type Details 




AUTO All low signal IQ excluded 






Episodes of desaturations 
screened and events which were 
due to poor signal conductance 
secondary to motion artefact, 
changing diapers, feeding or 
excessive motion were deleted 
Pugalenthi 
et al. (2013) 
Labchart software 
 
None No editing mentioned 






Took out all low signal IQ and all 
desaturation events were visually 
confirmed to exclude spuriously 
low values not identified by the 
software tool 
Lee et at. 
(2011) 
 MANUAL Suspect readings that occurred 
from unclear causes were retained 
by introducing a weighting 
function to down- weight them. 
This weighted each measurement 
between 70–100% by 1, while 
measurements between 0–69% 






MANUAL Deleted obvious artefact (defined 
as deflection to zero of both 






None No editing mentioned 





MANUAL Deleted obvious artefact (defined 
as deflection to zero of both 






None No editing mentioned 





MANUAL The pulse signal from the 
oximeter was recorded to exclude 
movement artefact 





MANUAL Traces printed onto graph paper 
and analysed by two doctors who 
visually took out low signal 





3.2.2 PROFOX Associates, Inc. software: options for editing artefact 
PROFOX Associates, Inc. software reports ‘low signal IQ’ which is indicative of when the 
signal is of low quality and therefore potentially not a true reading. How PROFOX 
calculates ‘low signal IQ’ is not explicitly defined in PROFOX’s manual or information 
sheets. It is stated that signal IQ is a signal identification and quality indicator of the pulse 
rate and oximetry data and measures signal quality using ‘advanced signal processing 
algorithms’ to create a confidence level, with ‘low signal IQ’ being displayed when there is  
<30% signal quality (172, 173). They state however, that a reading with a ‘low signal IQ’ 
is still highly likely to be an accurate recording (173).  If the signal is completely 
disrupted, the recording shows nothing (there is just a gap in the data).   
 
The papers Masimo reference in their Signal IQ technology information document (173) 
give inconsistent statements. One paper states a 75% specificity and a 100% sensitivity of 
‘low signal IQ’ to pick up false desaturations (172), with another stating that ‘low signal 
IQ’ displays in 80% of false desaturations to less than 85% SpO2, meaning 20% of false 
desaturations to less than 85% SpO2 would not display ‘low signal IQ’(174). Another 
independent paper studied 11 preterm infants in NICU and found that Masimo oximeters 
have a sensitivity of picking up true desaturations of 72.2 %, and a high false alarm rate at 
51% (ratio of false positive alarms and sum of true positive and false positive alarms). 
These rates were comparable to the other oximeter studied (Nellcor, Tyco Healthcare, 
Pleasanton California) (175).  
 
The PROFOX software, allows the operator to automatically delete all areas where there is 
‘low signal IQ’. There is also a manual editing section, enabling the operator to magnify 
sections to a minimum of five-minute intervals and manually remove any sections that 
appear to be artefact. Following editing, there is the option to ‘scan for aberrant data’, and 
delete these points. ‘Aberrant data’ is defined as any saturation data point where there is a 
difference in more than 10% SpO2 from the previous and subsequent data point, or a 
difference in twenty bpm from prior or subsequent data points for pulse (each data point is 
2 seconds apart) (169). 
 
The information available about PROFOX’s ‘low signal IQ’, and deleting all ‘low signal 
IQ’ as an artefact editing tool is not convincing as an accurate way of editing artefact from 
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data. We believed manually editing the data, using specific rules so consistency between 
recordings would be maintained, would be a better way of accurately editing artefact from 
a recording. We hypothesised that the measures reported in an oximetry report generated 
after manually editing data would be significantly different to reports from unedited or 
automatically edited data, and therefore be of consequence to the clinician interpreting the 
report.  
3.2.3 Deriving rules for manually editing data 
The aim was to develop rules for manual editing of oximetry data that would give 
reproducible results when applied to the data. We created rules with advice from experts 
that edit infant reports regularly and focused on practical rules that made logical sense. 
Three rules were created. The rules were applied with the data expanded so that 30-minute 
intervals were displayed on the screen. When applying rule number 3, 5-minute intervals 
were used to give more precise editing of an individual desaturation. The rules used were 
as follows: 
	
1) Delete any data at the very start or end of the trace until it reaches baseline. (So for 
the start of the trace, delete all data before a stable baseline is reached for at least 
30 seconds)   
2) Any areas where the data completely cuts out (either SpO2 or pulse), delete data 
before and after this gap until back to baseline on both sides of the data gap. 
3) At the end use the 'scan for aberrant data' function, and then choose to edit a larger 
area rather than just delete that point. Delete the whole desaturation that includes 
this aberrant data point, or associated desaturation with aberrant pulse data point. If 
this function identifies a desaturation that is part of a pattern of desaturations, do 
not delete the desaturation.   
	
Examples of applying these rules are displayed in figures 3-1 to 3-6. 
	
To validate these three rules, five infant discharge oximetry reports were picked at random. 
These three rules were applied to these five reports, and then a professional who edits 
infant oximetry reports regularly edited these same five reports manually according to their 
normal process of editing them (no written rules followed).  The results from the 
comparison of reported measures from these two methods are produced in table 3-1. As 
you can see, the manual rules created agreed with the expert edit. Most measures had a 
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median 0% difference, with the seven that did have some difference only ranging from 1% 
- 3.6% difference in value. 
	
To determine the significance of editing reports, each discharge oximetry report was 
produced three alternate ways and then compared for differences (see section 4 for results).  
 
1) Unedited: No change to original data 
2) Automatically edited:  PROFOX software’s options of ‘delete all low signal IQ’ used, 
and scan for any aberrant points, and deleted the individual point.  









Total recording time (minutes) 1 (0 - 7) 0% (0 - 0) 
Total valid recording time 
(minutes) 
11 (2 - 64) 1% (0 - 4) 
Highest pulse 0 (0 - 2) 0% (0 - 1) 
Lowest pulse 0 (-6 - 44) 0% (0 - 42) 
Mean pulse 0 (0 - 2) 0% (0 - 1) 
Highest SpO2 0 (0 - 0) 0% (0 - 0) 
Lowest SpO2 0 (-9 - 0) 0% (0 - 14) 
Mean SpO2 0 (0 - 0.2) 0% (0 - 0) 
1SD SpO2 0.1 (0 - 0.5) 3.6% (0 - 20) 
Time <90% SpO2 0.1 (0 - 0.9) 2% (0 - 50)  
Time <70% SpO2 0 (0 - 0) 0% (0 - 0) 
Time <88% SpO2 0.1 (0 - 0.7) 3% (0 - 54) 
DSI 4% - 0.2 (-3 - 1.3) 1% (0 - 3) 
DSI 3% - 0.2 (-3.5 - 1.2) 1% (0 - 3) 














































Values for 24-hour oximetry at discharge 
4.1 Methods 
4.1.1 Ethics 
Ethical approval was gained from the Otago Human Ethics Committee, reference H15/013 
(Appendix B). 
4.1.2 Participants and consent 
Infants were recruited from the Wellington Hospital regional, level three neonatal intensive 
care unit (NICU).  
 
Eligible infants were born at less than 37 weeks gestational age and to be discharged home 
from the unit to the Wellington region.  
 
Exclusion criteria were: 
• Likelihood of transfer to another hospital prior to discharge home. 
• Major congenital anomalies that interfere with cardiorespiratory function, such as 
lung malformations or structural abnormalities of the airways.  
 
The recruitment period ran from 2nd March 2015 to 11th September 2015. Posters were put 
up in the unit advertising the study to parents and information was distributed to all staff. 
Parents of all eligible infants who were to be discharged home from Wellington NICU 
during the recruitment period were approached and given additional information about the 
study. Infants were included in the study if their parents gave written consent.  
4.1.3 Clinical information collected 
Clinical information about each infant enrolled in the study was collected from the infant’s 
written medical notes in NICU and their discharge summary. Sex and ethnicity of the 
infant was recorded, as well as information on the infant’s antenatal period, 
birth/resuscitation, postnatal course in NICU, and current state at the time the discharge 
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oximetry recording was performed. A detailed list of clinical information collection can be 
found in Appendix C.  
4.1.4 Materials 
24-hour oximetry was used to measure infant respiratory stability at discharge. Devices 
used were one of two SET Rad-8 oximeters (Masimo Corp, Ivine CA).  
The oximeters were set to ‘sleep mode’, which meant the screen was blank and alarms 
were turned off so as to not interfere with the infant’s normal care. The averaging time was 
two seconds. The Masimo Rad-8 oximeters have a 2 second resolution time meaning a data 
point is recorded every 2 seconds. Before each recording any previous data were cleared 
from the oximeter.  
4.1.5 Data collection process 
As we were interested in infant respiratory stability at the time they were deemed clinically 
‘stable’ to be discharged home by current NICU protocol, we aimed to perform the 24-
hour oximetry as close to discharge as possible. We also ensured the infant had had no 
immunisations in the 48 hours prior to the study as immunisations have been shown to 
affect cardiorespiratory stability (176-178). All infants were placed to sleep on their back.  
 
At a time of day that was convenient, often coinciding with infant routine cares, the 
oximeter probe (MasimoSET LNOP Neo-L adhesive sensor, for <3kg or >40kg) was 
connected to the infant’s foot (right or left) (Masino instructions for use (169)) on the outer 
fleshy part, ensuring the LED emitter and sensor lined up. One sensor wrap was placed 
around the sensor and one on the leg to keep any outside light from affecting the sensor 
and to also help keep the sensor in place. The signal was checked and then the oximeter 
left to record data for 24 hours. A form was left with the infant for the parents and/or 
nurses to document the time of any feeds, cares, baths or disturbances to help with editing 
data.  
 
Following completion of the 24-h recording period, data were downloaded onto a laptop 
using PROFOX Associates, Inc. software (Escondido, United states).  
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Figure 4-1: Infant probe placement 
	
 




4.1.6 Data editing 
Comparison of three different ways of editing oximetry reports 
Each 24-hour discharge oximetry report was printed in three forms: 
 Raw: The data were not edited in any way 
 Auto: The data were edited automatically using the PROFOX software options  
o  ‘delete all low signal IQ’ 
o  'scan for aberrant points' (and deleted each point) 
Manual: The data were edited manually according to the following rules (see 
Section 3.2) 
o Delete any data at the very start or end of the trace until it reaches baseline.  
o Any areas where the data completely cuts out (either SpO2 or pulse), delete 
data until it reaches baseline on either side of this gap. 
o At the end use the 'scan for aberrant data' function, and chose to edit a larger 
area rather than just delete that point. Delete the whole desaturation that 
includes this aberrant data point, or associated desaturation with aberrant 
pulse data point, unless the desaturation is part of a section of similar 
desaturations.  
 
Editing oximetry reports to represent an 'overnight' study 
Each 24-hour discharge oximetry report was also edited to resemble a 12-hour 'overnight’ 
study. This was done to determine whether overnight recordings were a comparable 
alternative to a full 24-hour study. A 12-hour report was generated by selecting just the 
overnight portion of the oximetry recording from 8:00pm to 8:00am and saving it as a new 
report. 
4.1.7 Data analysis  
Data were entered into SPSS and all statistical analysis was done in this software. As the 
majority of variables were not normally distributed, medians and IQR or full range are 
presented. Exact Friedmans ANOVA was used to compared three ways of editing oximetry 






During the recruitment period (2nd March 2015  - 11th September 2015) there were 169 
preterm infants discharged from Wellington NICU, 80 of these were transferred to another 
unit prior to discharge home. Of the 89 infants that were discharged home from Wellington 
NICU, 28 were not approached due to either complex social issues or limited time as many 
of these infants were only admitted to the unit for a few days.  
 
Three infants were not approached as they had serious cardiac abnormalities, therefore 
excluding them from our study. Three infants died while in the unit. The remaining 55 
infants families were approached to participate in the study. Of these, 46 (83.6%) families 
consented to being involved in the study. The main reason for refusal was that the family 
did not want their baby to go back onto monitoring again. Two families withdrew from the 
study when it came time to do the 24-hour oximetry and three infants were missed due to 
early discharge. Two infants had the oximeter removed partway through the study, with 
only 2.5 and 8 hours total recording time, and therefore were excluded from analysis. 
Another family withdrew from the study part way through the oximetry recording (reason 




Figure 4-3: Recruitment process 
ii. Overall subject variables 
General demographics for the group of 38 participants included in the final analysis are 
presented in table 4-1. There were slightly more females (55.3%) than males (44.7%). 
Ethnicity distribution was diverse, with a large proportion (11/38, 28.9%) of participants 
identifying as NZ Maori and/or Pacific Islander. There were five sets of twins that 
participated in the study, and another two sets of twins where only one of the twins 






































Table 4-1 General demographics of participants included in analysis 
Variables N = 38 
Sex, n (%)  
   Male 17 (44.7) 
   Female 21 (55.3) 
Ethnicity*, n (%)  
   NZ European 23 (60.5) 
   NZ Maori 8 (21.1) 
   Pacific Island 9 (23.7) 
   Indian 4 (10.5) 
   Chinese 6 (15.8) 
   Other European 5 (13.2) 
Multiple birth, n (%) 14 (36.8) 
GA at birth (weeks), median (range) 32.5 (24 - 36) 
* participants could identify as more than one ethnicity  
iii. Antenatal variables of participants 
There were 12/38 (31.6%) participants whose mothers did not receive steroids prior to 
their birth, 44.7% that received a full dose (two doses of steroids prior to birth), 18.4% 
who only receiving a partial dose (normally one dose too close to birth to administer a 
second dose) and 5.2% receiving multiple doses of steroids. In the extreme to very preterm 
infants subgroup (<32 week GA), only 3/12 (25%) of participant mothers did not receive 
steroids prior to their birth. There were six (15.8%) infants whose mothers smoked, and 
two cases of chorioamnionitis, both of which were suspected rather than confirmed on 
histology.  
iv. Birth and resuscitation variables of participants 
The birth and resuscitation variables for all participants are summarised in table 4-2. As 
well as presenting data for all participants, two subgroups are presented: extremely and 
very preterm infants (<32 weeks GA), and moderate to late preterm infants (≥32 weeks 
GA). The majority of births were by caesarean section, with one set of twins being born 
electively at 36 weeks GA, and the rest being born by emergency caesarean section. Of all 
the participants, there were four born small for gestational age (SGA) (defined as <10% 
centile birth weight for GA), all in the moderate to late preterm group. All extreme to very 
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premature infants needed some form of resuscitation at birth, with 50% of this group 




Table 4-2 Birth and resuscitation variables of participants 
Variables < 32 weeks 
GA (n = 12) 
≥32 weeks 
GA (n = 26) 
All  
(n = 38) 
Method of delivery, n (%)    
   Caesarean section 8 (66.6) 16 (61.5) 24 (61.2) 
   Normal vaginal delivery 4 (33.3) 10 (38.5) 14 (36.8) 
    
Birth weight (grams), mean (SD) 1243 (373) 2108 (420) 1835 (541) 
Birth weight <10th centile, n (%) 0 (0) 4 (15.4) 4 (10.5) 
Birth head circumference (cm), mean (SD) 26.8 (2.48) 31.4 (1.59) 29.9 (2.8) 
Birth length (cm), mean (SD) 38.2 (3.74) 43.6 (2.68) 41.9 (3.9) 
APGAR*, median (range)    
   1 minute 6.5 (2-9) 8 (3-9) 8 (2 - 9) 
   5 minutes 8 (7-10) 9 (6-10) 9 (6 - 10) 
   10 minutes 10 (9-10) 10 (8-10) 10 (8 - 10) 
Resuscitation at birth, n (%)    
   Nil required 0 (0) 7 (26.9) 7 (18.4) 
   Inflation breaths only 0 (0) 1 (3.85) 1 (2.6) 
   IPPV or CPAP (total) 12 (100) 18 (69.2) 30 (78.9) 
      With oxygen 11 (91.7) 14 (53.8) 25 (65.8) 
         Required intubation 6 (50) 2 (7.7) 8 (21) 




v. Course of NICU stay  
The group of participants overall had an uneventful NICU stay. The >32 weeks GA 
subgroup had few complications, with just one requiring surgery for bilateral inguinal 
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hernia and another infant that had gastro-oesophageal reflux requiring medication. The 
median (range) highest SBR during an infant’s stay (all infants) was 233 (99-363).  
 
In the < 32 weeks GA subgroup there were 2/12 (16.6%) infants that had an IVH, both 
grade one, and 4/12 (33.3%) infants that required treatment for a PDA, with two only 
needing one dose of indomethacin, one needing four doses and one needing six. In this 
subgroup there were 5/12 (41.7%) infants that had ROP, with four being stage one and one 
classed at stage three that required laser therapy. Of the 12 infants in this subgroup, five 
(13.1%) required blood transfusions, with four infants only needing one or two 
transfusions and one infant needing ten. There was only one recorded case of sepsis 
(confirmed by blood culture).  
vi. Respiratory variables 
Table 4-3 summarises the respiratory course of all participants and the two subgroups. 
There was only one infant requiring ventilation by endotracheal tube and this infant was 
went on to develop CLD. All infants born <32 weeks received caffeine, while only 23.1% 
of infants in the >32 GA group received caffeine. The median PMA that infant monitoring 
was stopped was 36 weeks and did not vary between subgroups. Although the minimum 
time that infants were monitored after stopping caffeine was five days, the median time 
monitored was longer at nine days. Of the <32 weeks GA subgroup, 6/12 (50%) had at 
least one Masimo 24-hour pulse oximetry study which was downloaded and reported 
during their NICU stay, with a total of 9/38 (23.7%) of all infants. Four had this done more 
than two weeks prior to discharge, 2/9 had this done as a 'fit to fly' test as they were flying 
home (overseas). Just three of the 38 study infants (7.9%) had the Masimo 24-hour 
recording done as an assessment for respiratory stability for discharge. 
vii. Participant status at time of discharge oximetry study 
The 24-hour oximetry study was completed as close as possible to the infant’s discharge 
home. Most infants (52.6%) were discharged home on the same day as completion of their 
24-hour oximetry. All but one infant were discharged home within four days of completing 
the oximetry study (median 0 days, range (0-8)). At the time of the 24-hour oximetry 
study, infants were generally well as they were about to be discharged home. Variables are 
described in table 4-4. Postmenstrual age at the time of study varied from 35 to 42 
completed weeks. There were two infants who had monitoring from a hospital pulse 
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oximeter at the same time as the study 24-hour pulse oximetry recording. One of these 
infants was the infant for whom there was clinical concern about apnoea, and the other was 
an infant on supplemental oxygen who still had continuous pulse oximetry monitoring and 
went on to be discharged home with a pulse oximeter. 
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Table 4-3 Respiratory course of participants  
Variables 
< 32 weeks GA 
(n = 12) 
≥32 weeks GA 
(n = 26) 
All  
(n = 38) 
Required endotracheal ventilation during NICU stay*, n (number of 
days ventilated) 1 (15) 0 (0) 1 (15) 
Required CPAP during NICU stay*, n (%) 9 (75.0) 5 (19.2) 14 (36.8) 
Days on CPAP* 21 (2-68) 6 (4-9) 8 (2 - 68) 
Required additional oxygen during NICU stay*, n (%) 11(91.7) 8 (30.8) 19 (50.0) 
Days on oxygen* 38 (2-124) 6.5 (2-18) 10 (2 - 124) 
Received caffeine, n (%) 12 (100) 6 (23) 18 (47) 
Days on caffeine 41 (19-86)  20 (6-25) 26 (1-86) 
PMA when caffeine stopped (weeks) 34+5 
(33+6 - 38+1) 
35+1 
(34+5 - 36+2) 
34+6  
(33+6 - 38+1) 
Days on monitoring# 51 (25 - 124) 12 (0 - 34) 24.5 (0 - 124) 
PMA when monitoring discontinued (weeks)$ 36+3 
(34+5 - 42+1) 
36+1 
(35+4 - 39+2) 
36 
(34+5 - 42+1)  
Days monitoring after caffeine stopped  8.5 (5 - 38) 9 (5-28) 9 (5-38) 
Received Massimo study during NICU stay, n (%) 6 (50.0) 3 (11.5) 9 (23.7) 
CLD 1 0 1 
Values are median (range) unless stated. 
*Only including infants with  > 1 day on respiratory support (excluding resuscitation at birth) 
# Either full ECG and oxygen saturation monitoring or pulse oximetry only 
$ n = 35 (All), n = 23 (>32 weeks GA) (only including infants that had monitoring) 
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Table 4-4 Status of participants at time of discharge oximetry 
Variables 
Number (% - unless stated)  
(n = 38) 
PMA (weeks), median (range) 37+1 (35+6 – 42+5) 
Weight (grams), median (range)* 2487 (1806 - 3900) 
Method of feeding n (%)  
Breast only 6 (15.8) 
Bottle only 7 (18.4) 
Breast (mainly) and bottle top ups 22 (57.9) 
Bottle and NG top ups 3 (7.9) 
Type of milk  
Breast milk 19 (50.0) 
Formula 5 (13.2) 
Formula and breast milk 14 (36.8) 
Most recent Hb (g/L), mean (SD) 134.1 (36.2) 
Number of days since most recent 
Hb, mean (SD) 4.2 (3.8) 
Clinical concern for apnoea at time of 
study 1 (2.6) 
On oxygen 1 (2.6) 
Currently monitored# 2 (5.3) 
Time from study to discharge (days), 
median (range) $ 0 (0-8) 
* n = 36 
#Masimo 
$From end of 24 hour oximetry until discharge home  
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4.2.2 Results of 24-hour discharge oximetry 
i. Comparison of oximetry measures from unedited, automatically edited 
and manually edited data  
Valid recording time  
 
Table 4-5 Total valid recording time 










The amount of total valid recording time remaining after editing differed significantly 
between the three ways of editing X2 (2, N=38) = 76.00, p = < 0.0001. Automatically and 
manually edited reports always had less valid recording time than raw data, and auto 
always had less valid recording time than manual. Automatically editing the data reduced 
the median valid recording time by 1 hour 42 minutes, while manually editing the data 
only reduced the median valid recording time by 13 minutes.  
	
Oximetry measures 
Table 4-6 summarises the median value for each oximetry measure, presented for each of 
the three ways of editing the data: no editing (Raw), edited only by the automatic function 
in PROFOX (Auto), and manually edited (Manual). Based on the exact Friedmans 
ANOVA test, there are significant differences between the different ways of editing for all 
oximetry measures listed. Pairwise Freidmans test (adjusted for multiple comparisons 
using p = <0.017) were performed to see where the differences lay (table 4-7). For the 
majority of measures, manually editing produced more severe measures of intermittent 
hypoxia (e.g a higher DSI 4%). The mean SpO2 and percentage time spent below 90% 




Table 4-6 Comparison of variables after different editing methods 
Measures Raw Auto Manual P Value* 
Mean SpO2 (%) 97.8 
(97.1 − 98.7) 
97.9 
(97.2 − 98.8) 
97.9 
(97.3 − 98.8) 
<0.0001 
Lowest SpO2 (%) 60.0 
(45.5 − 66.0) 
61.5 
(50.8 − 69.8) 
65.0 
(52.3 − 76.0) 
<0.0001 
Time spent <90 SpO2 (%) 1.95% 
(0.80 − 4.68) 
1.30% 
(0.70 − 4.13) 
1.25%  
(0.70 − 4.20) 
<0.0001 
Time spent <80 SpO2  (%) 0.2% 
(0.1 − 0.6) 
0.2% 
(0 − 0.4) 
0.1% 
(0 − 0.4) 
<0.001 
DSI 4% (events/h) 53 
(34 – 76) 
51 
(31 − 74) 
53 
(33 − 75) 
<0.0001 
DSI 3% (events/h) 80 
(55 − 105) 
77 
(53 − 103) 
80 
(54 − 105) 
<0.0001 
DSI 4% > 10secs 
(events/h) 
13.6 
(8.9 − 17.8) 
10.7 
(7.0 − 15.1) 
13.5 
(8.6 − 17.6) 
<0.0001 
Mean pulse (bpm) 157 




(148 − 163) 
<0.0001 
Highest pulse (bpm) 214 
(208 − 221) 
212 
(203 − 221) 
213 
(207 − 221) 
<0.0001 
Lowest pulse (bpm) 39 
(27 − 57) 
54 
(31 − 68) 
91 
(80 − 102) 
<0.0001 
*Exact friedman's ANOVA used (df =2) 














Table 4-7 Difference between manual and automatic editing 
No difference Manual improved value 
from Auto (p < 0.017) 
Manual value worse than 
Auto (p < 0.017) 
Mean SpO2 
Lowest SpO2 
Time spent <90% SpO2 
Mean Pulse 









Percentage difference of editing measures compared to raw 
Although all oximetry measures were significantly different when edited the three ways, 
some of the actual oximetry measures values only differed by a small amount that is 
unlikely to be clinically significantly different, e.g. median highest pulse: 213.5 (raw), 212 
(auto), 213 (manual). To help visualise how significant the difference in the oximetry 
values were after editing, the percentage difference for the raw compared to each the 
automatically edited data, and the manually edited data was calculated: (AUTO-
RAW)/RAW * 100 and (MANUAL-RAW)/RAW * 100.  
 
The change in value after editing with either automatically, or manually edited data for 
median SpO2, lowest SpO2, DSI 4%, DSI 3%, median pulse, and highest pulse was less 
than 5%. It is unlikely that a change in value of less than 5% from the original value would 
have clinical implications, so for these measures, editing oximetry reports (either 
automatically or manually) is unlikely to make a clinically significant difference. 
 
Time spent below 90% SpO2, and DSI 4% > 10 seconds had the greatest change in value 
from the raw data after automatically editing, with more than 10% changes. For manual 
editing, <90 SpO2, <80 SpO2 and lowest pulse had more than 5% changes from the raw 




Table 4-8. Comparison of variables after different editing 
  Auto Manual 













(0 − 0.4) 
-0.1 
(0 − 0.1) 
0.1 
(0 − 0.2) 
-0.1 




(0 − 37) 
0 
(0 − 11.5) 
0 
(0 − 60) 
0 





(-1.9 − 0) 
-13.8 
(-21.3 − -6.5) 
-0.2 
(-1.6 − 0) 
-10.4 





(-0.5 − 0.1) 
-2.1 
(-33.3 − 0) 
-0.1 
(-0.6 − 0) 
-7.5 




(-6.5 − 1.9) 
-3 
(-6.3 − -1.5) 
-0.1 
(-1.9 − 1.5) 
-0.4 




(-7.7 − 2.8) 
-2.3 
(-4.1 − 1) 
0 
(-2.1 − 1.4) 
0 
(-0.1 − 0.6) 




(-6.3 − 0.6) 
-18.4 
(-23.2 − 12.3) 
-0.1 
(-1.1 − 0.1) 
-1.4 




(-4 − 0) 
-0.7 
(-1.2 − 0.6) 
0 
(-1 − 1) 
0 




(-12 − 0) 
0 
(-1.43 − 0) 
0 
(-12 − 0) 
0 




(0 − 67) 
0 
(0 − 20.5) 
48.5 
(0 − 80) 
101.9 
(-38.8 − 240.2) 
 




Overall, it would appear that for the majority of measures, the editing of oximetry reports, 
either automatically or manually, would be unlikely to result in any clinically significant 
differences. Measures that are more likely to change by a larger percentage are lowest 
pulse/lowest SpO2, time spent below 90% and DSI4% >10 seconds, with only DSI 4% >10 
and lowest pulse having a >10% percentage difference between automatically editing and 
	 67	
manual editing. Automatically editing underestimated the severity of DSI4% >10 s by a 
median of 17% less than manual editing, and overestimated (101.9%) how low the pulse 
nadir was compared with manual editing. For DSI 4%, although this is a 17% median 
difference, the actual median value of 10.7 events/h compared to 13.5 is marginal as to 
whether this would be considered clinically significant. Therefore, as for the majority of 
measures there is no clinically significant difference between manual editing and 
automatically editing, and automatically editing often does help edit artefact from results, 
from here on, all oximetry results presented will be those that were automatically edited. 
ii. 24-hour oximetry (automatically edited) – measures of intermittent 
hypoxia 
Figures 4.4 – 4.7 show the spread of values for four measures of intermittent hypoxia. The 
majority of infants (79%) had on average, between 40 and 119 3% desaturation events per 
hour, or one or two episodes per minute (figure 4.1). When looking at 4% desaturations 
longer than 10 seconds, the majority of infants (76%) had six to twenty episodes per hour 
(figure 4.3). A higher value in any of the four measures was correlated with higher values 
for the other three measures. (All statistically significant p = < 0.004 (spearman’s 


















































































DSI 4% >10 seconds 
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Figure 4-7 Percentage time spent below 90% SpO2 for all infants 
	
	
Table 4-9 Inter-correlation between intermittent hypoxia measures 




DSI 3%    r = 0.976 
p < 0.0001 
r = 0.610 
p < 0.0001 
r = 0.821 
p < 0.0001 
DSI 4%  	  r = 0.494 
p = 0.003 
r = 0.852 





  r = 0.470 
p = 0.004 
r =spearman’s rank correlation coefficient (two tailed) 
	
iii. Relationship between infant characteristics and 24-hour oximetry 
data.  
Figure 4.8 shows the negative relationship between DSI 4% >10 seconds and PMA, of the 
four intermittent hypoxia measures. This was the only significant correlation found. When 
plotting age in days against intermittent hypoxia measures, again only DSI 4%  > 10 

























Figure 4-8 DSI 4% > 10 seconds vs PMA 
 
	
The number of days on caffeine, birth weight, discharge weight and highest SBR during 
NICU stay were not significantly correlated with any of the intermittent hypoxia measures. 
Days spent on O2, GA, and most recent Hb were all correlated with some but not all of the 




Table 4.10 Infant characteristics correlation with intermittent hypoxia at discharge 
 Days on O2 Most recent Hb GA 
DSI 3% r = 0.335 
p = 0.040 
r = -0.050 
p = 0.766 
r = -0.313 
p = 0.056 
DSI 4% r = 0.401 
p = 0.013 
r = -0.132 
p	=	0.430	
r = - 0.379 
p = 0.022	
DSI 4% >10seconds r = 0.002 
p	=	0.989	
r = 0.418 
p = 0.009 
r = 0.157 
p	=	0.347	
Times spent <90% r = 0.406 
p = 0.011 
r = -0.082 
p	=	0.623	
r = - 0.327 
p =  0.045 




























coefficient - 0.369 (p = 0.011) 
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Intermittent hypoxia, measured by the four measures listed above did not differ 
significantly when Pacific Island and Maori ethnicity as a sub group were compared with 
other ethnicities. Intermittent hypoxia when compared by subgroups of smoking during 
pregnancy or being male or female also did not differ significantly. The need for oxygen 
during resuscitation at birth was associated with significantly higher values for DSI 4% (p 
= 0.025) and time spent below 90% (p = 0.03), but not for DSI 4% >10seconds (p = 0.447) 
or DSI 3% (p = 0.06). Infants born by NVD had significantly lower values for DSI 3% and 
DSI 4% at discharge than infants born by caesarean section. (2 – tailed, exact Wilcoxon 
rank sum test used). 
	
4.2.3 Comparing 24-hour with 12-hour oximetry 
The results of the comparisons of 24-hour oximetry with the shortened, overnight 12-hour 
oximetry are presented in table 4-11. There were three cases where the shortened overnight 
oximetry gave a total valid recording time of < 6 hours; these cases were excluded from 
analysis (n = 35). The median total valid recording time was 11 hours 17 minutes, range (9 
hours 7 minutes - 11 hours 50 minutes).   
 
Variables that changed significantly when the trace was cut to an overnight 12 hour trace 
were lowest SpO2 and lowest pulse, as well as percentage time spent below 90% and 80% 
SpO2. None of the three desaturation index measures (measures of intermittent hypoxia) 
changed significantly. Of the measures that did have statistically significant changes, only 


















Table 4-11 24-hour vs 12-hour oximetry comparison 
Measures 24-hour 12-hour P value* 
Mean SpO2 (%) 97.8 (97.2 − 98.8) 97.8 (97.2 − 98.8) 0.455 
Lowest SpO2  (%) 62 (53 − 72) 69 (58 − 77) <0.001 
Time spent <90 SpO2 (%) 1.2 (0.6 − 4.2) 1.1 (0.5 − 4.3) 0.05 
Time spent <80 SpO2 (%) 0.1 (0 − 0.4) 0.1 (0 − 0.5) 0.017 
DSI 4% (events/h) 50.8 (31.1 − 79.5) 54.6 (32.1 − 79.7) 0.499 
DSI 3% (events/h) 78.5 (53.4 − 104.4) 79.2 (50.2 − 104) 0.579 
DSI 4% > 10secs (events/h) 10.9 (7.1 − 15.3) 11.3 (6.5 − 14.7) 0.258 
Mean pulse (bpm) 156 (147 − 161) 155 (148 − 160) 0.407 
Highest pulse (bpm) 210 (203 − 221) 209 (201 − 215) <0.001 
Lowest pulse (bpm) 54 (28 − 69) 78 (54 − 96) <0.001 
All median (IQR) 
*Wilcoxon signed rank test 
	
Table	4-12	Percentage	differences	between	24-hour	and	12-hour	oximetry 




Percentage change from 
24-hour, %** 
Mean SpO2 (%) 97.9 0 (-0.5 – 0.9) 0 (-0.5 – 1) 
Lowest SpO2 (%) 61.5 1 (0 − 22) 1.2 (0 − 58.8) 
Time spent <90 SpO2 
(%) 
1.3 -0.1 (-2.5 − 1.2) -2.6 (-66.7 − 60) 
Time spent <80 SpO2 
(%) 
0.2 0 (-1 − 0.3) 0 (-100 − 150) 
DSI 4% (events/h) 51 -0.3 (-14.4 – 7.1) -0.6 (-29.9 – 12.4) 
DSI 3% (events/h) 77.4 -0.1 (-16.3 – 10) -0.1 (-24.5 – 15.9) 
DSI 4% > 10secs 
(events/h) 
10.7 -0.3 (-3.4 – 2.3) -3.3 (-41 – 22.1) 
Mean pulse (bpm) 155.5 0 (-3 − 3) 0 (-2.1 – 2.1) 
Highest pulse (bpm) 212 0 (-18 − 0) 0 (-8.1 − 0) 
Lowest pulse (bpm) 53.5 11 (0 − 90) 32 (0 − 360) 
* Median (range) 




Impact of intermittent hypoxia on post-discharge growth 
and change in 24-hour oximetry one-month post 
discharge 
5.1 Methods 
5.1.1 Participants  
All infants from the main study who were born less than 32 weeks GA were included in 
the follow up study (n=12). 
5.1.2 Additional clinical information collected 
Wellington NICU routinely records weekly weights, head circumference and length for all 
infants in the unit. These growth measurements were collected. Discharge growth 
measurements were also recorded.  
5.1.3 Data collection process 
i. Weekly growth measurements 
Infant weight, head circumference and length were recorded at least once a week for four 
weeks after discharge and final measurements recorded on the date of the home 24-hour 
oximetry. Most infants were being visited at home by the Wellington NICU home care 
nursing team at least once a week so wherever possible these visits were attended with the 
home care team and the measurements taken at this visit used (infant weight, head 
circumference and length). If the homecare team had discharged the infant from their care, 
additional visits were made where needed. Measurements from the homecare teams 
medical notes were obtained for visits we were unable to attend. If needed, the infant’s 
Plunket book was also checked for any measurements done by the midwife/Plunket. These 
various methods of data collection were utilised for practical reasons and to ensure we had 
at least one set of measurements a week.  
	
Growth data were entered into a SPSS spread sheet and Z scores for weight were 
calculated using the 2013 Fenton growth charts online calculator (179). The rate of change 
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in Z score (for weight) over the follow up period was calculated. The rate of change in Z 
score was used to correlate with intermittent hypoxia measures on discharge oximetry 
using 2-tailed spearman’s rank correlation.  
 
Z-scores have been used to assess growth rates, rather than percentage weight gain or 
percentiles from growth charts. This is because preterm infants are discharged home at 
different maturity levels and therefore growth rates would be different. Clinicians track 
infant growth by plotting weight on growth charts and are only concerned when an infant’s 
weight starts falling below the percentile curve they were tracking on, rather than simply 
keeping track of weight gain. Z-scores control for base differences in infant weights and 
are also the only growth measurements that have been shown to have some statistically 
significant correlation with neurodevelopmental outcomes in childhood (180).   
ii. Home 24-hour oximetry recording 
As close to four weeks after discharge as possible a repeat 24-hour oximetry recording was 
done on the infants in their home. The same oximeters (Masimo Rad-8) as the initial 




There were 12 infants recruited for the study that were born <32 weeks GA and eligible for 
the post-discharge, follow up phase of the study.  All consented to be included in this 
follow up phase. Table 5-1 presents demographic data for this group, 4/12 (33.3%) 













Table 5-1 General demographics of participants <32 weeks GA included in analysis  
Variables N = 12 
Sex, n (%)  
   Male 3 (25.0) 
   Female 9 (75.0) 
Ethnicity*, n (%)  
   NZ European 5 (42.7) 
   NZ Maori 3 (25.0) 
   Pacific Island 4 (33.3) 
   Indian 2 (17.7) 
   Chinese 3 (25.0) 
Multiple birth, n (%) 4 (33.0) 
GA at birth (completed weeks), median 
(range) 29 (24 - 31) 
* participants could identify as more than 
one ethnicity  
 
5.2.2 Impact of intermittent hypoxia on growth rates post discharge 
Three variables measured on 24-hour discharge oximetry that identify intermittent hypoxia 
(3% DSI, 4% DSI for >10seconds, and percentage time spent <90%) were compared with 
growth rates after discharge (rate of change in Z scores for weight). None of these 
correlations were statistically significant; However, time <90% SpO2 did show an 
























Figure 5-2 DSI 4% > 10 seconds and growth rate comparison 
Spearman’s correlation 
coefficient 0.56 (p = 0.863) 
	
Spearman’s correlation 




Figure 5-3-Percentage time spent <90%SpO2 and growth rate comparison 
5.2.3 Discharge oximetry compared with oximetry performed four weeks 
post discharge 
The follow up 24-hour oximetry was performed as close to four weeks (28 days) after 
discharge as possible (median 29 days, range 27 − 32). There were 2 infants (from a set of 
triplets) who did not complete the follow up oximetry due to difficulty with follow up. One 
infant only had 5 hours 43 minutes of valid recording time for the follow up 24-hour 
oximetry, so was excluded from analysis (n = 9).  Of the nine follow up 24-hour oximetry 
reports included in this analysis, the median valid recording time was 22 hours 4 mins 
(range: 21 hours 0 mins - 23 hours 0 mins) 
	
Table 5-2 compares discharge 24 hour oximetry measures with the 4 week post discharge 
home 24 hour oximetry. All desaturation index measures (DSI 3% (p = 0.02), DSI 4%(p = 
0.01) and DSI 4% > 10 seconds (p = 0.04)) were significantly improved (lower values). 
	
Table 5-3 presents the actual value of the change in measures as well as the percentage 
change.  Of the five measures that had statistically significant differences, the change in 
Spearman’s correlation 
coefficient -0.222 (p = 0.484)	
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values for the three desaturation index measures and percentage time spent <90% SpO2 






Table 5-2 Home oximetry compared with discharge oximetry (n-9) 





Mean SpO2 (%)  98.5 (95.8 − 99.2) 98.7 (98 − 99.4) 0.13 
Lowest SpO2 (%) 57 (34 − 77) 68 (39 − 78) 0.29 
Time spent <90 SpO2 
(%) 
1.4% (0.6-9.8) 0.6% (0.3 – 1.6) 0.02 
Time spent <80 SpO2 
(%) 
0.2% (0.1-1.3) 0%  (0 − 0.15) 0.11 
DSI 4% (events/h) 57.9 (25.1-132.2) 25.5 (7.2 − 49) 0.01 
DSI 3% (events/h) 80.1 (35.3-153.1) 41.5 (13.2 − 64.8) 0.02 
DSI 4% > 10secs 
(events/h) 
7.7 (4 − 15.9) 5.2 (1.9 – 9.5) 0.04 
Mean pulse (bpm) 154 (144 − 160) 150 (136 − 153) 0.03 
Highest pulse (bpm) 205 (186 − 221) 200 (184 − 217) 0.21 
Lowest pulse (bpm) 60 (25 − 92) 53 (25 − 94) 0.25 
* Median (IQR) 
**Wilcoxon signed ranks test 
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Table 5-3 Percentage differences between discharge and home 24-hour oximetry 
Measures Median 
(discharge) 
Change from discharge 
(home - discharge) * 
Percentage change 
from discharge* 
Mean SpO2 (%)  98.5 0.8 
(-0.9 − 3.50) 
0.8 




(-23 − 32) 
19 
(-31.9 − 94.1) 
Time spent <90 
SpO2 (%) 
1.4 -0.5 
(-9.2 − 0.2) 
-55.5 
(-93.9 − 14.3) 
Time spent <80 
SpO2  (%) 
0.2 -0.1 
(-2.4 − 0.8) 
-96 




(-106.1 − 6.8) 
-50.1 




(-116.2 − 13.1) 
-42.7 
(-83.5 − 37.1 ) 




(-13.5 − 5.5) 
-57.4 




(-9 − 2) 
-4.5 




(-13 − 12) 
-1.1 




(-63 − 36) 
-13.1 
(-68.5 – 112.0) 






In this study there were 38 premature infants who, just prior to discharge home from 
Wellington NICU, had a valid 24-hour oximetry recording performed. Of the 38 
participants, 12 were born at less than 32 weeks gestational age and participated in the 
second part of the study which included recording weekly growth measurements for one 
month post discharge, as well as performing a repeat 24-hour oximetry in their home one 
month after discharge.  
	
The proportion of Maori infants in this participant group was 21.1%, which is comparable 
to NZ Ministry of Health (MOH) data for the year 2014 that shows 25.8% of all infants 
born were of Maori ethnicity (2). Our study population is slightly over representative of 
normal local rates for Maori ethnicity of preterm infants, with 17.5% of preterm infants 
admitted to Wellington NICU in 2014 identifying as Maori (181). There were a high 
proportion of Pacific Island infants in our study group (23.7%), higher than the MOH data 
of 10%. This could be in part due to the fact we had a set of triplets that were of Pacific 
Island decent that increased this group number. The majority of infants were born by 
caesarean section (61.2%), which is slightly higher than the MOH figures for rates of 
caesarean section for preterm infants of 46%. Most infant participants needed some 
resuscitation at birth (57.9% had some resuscitation but without intubation). Half of infants 
(47.4%) received caffeine treatment during their NICU stay. Being of Maori, Pacific 
Island, or NZ European ethnicity made no significant difference to intermittent hypoxia 
values.  
	
The 38 pre-discharge oximetry recordings were analysed in PROFOX software three 
alternative ways (unedited, automatically edited and manually edited) and compared for 
differences. There were only a few measures on oximetry reports that were clinically 
different between type of editing, and therefore we consider automatic editing as the most 
practical way to edit data.  
	
The pre-discharge 24-hour automatically edited recordings were further reported and 
analysed. We found that this group of formally premature infants had a high mean SpO2, 
however a large amount of intermittent hypoxia was seen. The recordings were also edited 
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to resemble a 12-hour ‘overnight’ oximetry study and the results compared with the full 
24-hour recording. The edited ‘overnight’ recordings were found to be clinically similar to 
the 24-hour recordings, the pulse nadir being the only clinically significant difference 
between the two. 
 
For the twelve infants born <32 weeks GA, post-discharge growth (in the form of change 
in z-score) were compared with degree of intermittent hypoxia on discharge oximetry 
report, no significant correlation was found. When comparing discharge oximetry with 
home oximetry 1-month post discharge, mean SpO2 did not change significantly, however 
all four measures of intermittent hypoxia had a statistically and clinically significant 
improvement. These results highlight the significant amount of intermittent hypoxia still 
experienced by convalescent preterm infants at the time of their discharge home from the 
neonatal unit. The decrease in levels after one month at home agrees with our hypothesis 
that the levels of intermittent hypoxia in very preterm infants will have decreased one 
month post-discharge; however, there will still be a degree of intermittent hypoxia. We 
hypothesised that there would be a correlation between the amount of intermittent hypoxia 
experienced at time of discharge and infant growth rates post discharge, however, this 
study did not show any correlation.  
6.1 Discussion of results 
6.1.1 24-hour discharge oximetry results 
For these results discussed, values produced by automatic editing are used. The baseline 
oxygen values in these infant studies were always normal with a median ‘mean SpO2’ for 
all studies of 97.9%. This is consistent with other similar studies as reported in section 
2.3.4. These studies reported medians of 95 - 99.4% but these studies were undertaken 
using a variety of oximeter devices (70, 80, 83, 84, 86, 87, 89). 
 
The median percentage time spent <90% SpO2 was 1.3%, which is less than other reported 
studies (2.2 - 5.6%) (6, 80, 83, 84). Of these four studies, there were two which used 
Nellcor oximeters and performed the oximetry recording earlier than ‘at discharge’ 
meaning the infants would have been less mature, possibly a reason for the two higher 




The most similar study reported previously used Masimo Rad 7 oximeters, assessed the 
infant at discharge, and used PROFOX software to perform automatic editing on 
recordings. Although the study only included infants born <32 weeks GA, it still gave the 
closest value for percentage time spent <90% SpO2 to our study of 2.2% (83). When 
analysing just infants <32 weeks GA in our study group, the percentage time spent less 
than 90% SpO2 was 2%, which is in fact very similar to this study. This study was also the 
only study in our literature review to report a desaturation index. They report a value for 
median DSI 4% >10 seconds of 10.2 events/h, which is very similar to the median of 10.7 
events/h found in the current study. This value of 10.7 events/h is the full study group <37 
weeks GA.  The sub group of <32 week GA infants had a lower DSI 4% >10 seconds of 
7.7 events/h. 
 
Rath et al. published the most recent study reviewed (December 2015), and did assess 
infants ‘at discharge’; however, only infants less than 28 weeks GA were included, the 
sample size was small (15 infants), and again they did not report any desaturation index 
values (80). The percentage of time spent less than 90% SpO2 for this group was 3%, also 
in keeping with our result of 2.2%.  
	
Our study results add significantly to this literature as we report ‘normal’ values, for 
preterm infants thought to be clinically well, for oximetry measures produced from new 
generation oximeters, using the most used oximetry software PROFOX in Australian and 
New Zealand neonatal units (69). We also report values for the intermittent hypoxia 
measures DSI 3% and DSI 4 %, which no study has yet reported, and DSI 4% >10 seconds 
(events/h), which only one previous study has previously reported although only for 
<32week GA infants. Our study is also the first study to report automatically, manually 
and unedited results, meaning our results are able to be applied to a greater number of 
reports as some centres may choose to edit data, while others may just use the raw data, 
and both could use our reported values (either using the edited or unedited forms) as a 
guide when interpreting their results.  
	
We have presented oximetry values for convalescent preterm infants who are ready for 
discharge home from the neonatal unit (table 4.6). Comparison to values in healthy term 
infants is needed to be able to evaluate whether these values in preterm infants should be 
considered abnormal and therefore worrying. These results may be ‘normal’ or perhaps 
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‘expected’ for preterm infants at this stage in their development but still have implications 
for their long-term outcomes. There are five studies to our knowledge that report oximetry 
values for healthy term infants within the first week of birth (comparable PMA to our 
infants) (6,76, 80, 83, 182, 183). The median ‘mean SpO2’ for these studies were 97 - 99%, 
which is very similar to our study (97.9%). Four of the six term infant studies used 
Masimo technology, so are comparable to our study. 
	
Rhein et al. compared term infants in the first week of life with preterm infants off oxygen 
and ready for discharge home. They are the only other study to report desaturation index 
values and they also used 2-second averaging times and new generation Masimo oximeters 
(83). They report that while mean SpO2 and time spent below 90% SpO2 was comparable 
between the two groups, median DSI 4% > 10 seconds differed significantly (preterm 10.2 
events/h vs term 8.2 events/h (p= 0.0001)) (83). As our preterm infant median for DSI 4 % 
> 10 seconds was 10.7 events/h, their term infant value of 8.2 events / h is also 
significantly better than our preterm infants population.   
 
The only other comparable measure to our study that was reported in these studies was 
percentage time spent <90% SpO2. Ng et al. report a median of 2.3% (0.1 – 4.7), Rhein et 
al. report a median of 2.6% (1.5 - 4.6), while Rath et al. report 0% (0 - 0.8) (80,83,182). 
All studies used Masimo Rad-7 technology and used the delete low signal IQ function, 
with similar exclusion criteria. Rath et al. only had 15 infants in each group (term and 
preterm), while the other two studies had 60 term and 100 term infants each. It is unclear 
why Rath et al. report such different values to the previous two studies, however as their 
sample size was a lot smaller, the first two studies may be a more accurate representation. 
In this case, the time spent <90% SpO2 for term infants from reported studies (2.3-2.6 %) 
is comparable to the 2.2% value seen in our preterm infant population. 
 
Shah et al. used Nellcor oximeters and so the results from their study are not as comparable 
as this technology differs from the MasimoSET technology used in this study. They 
reported that the median percentage time <90% SpO2 was 3.4 – 3.6% for term infants, a 
significant difference from their late preterm group (5.6%) (p = 0.002) (6). 
	
As can be seen, there are no studies that report DSI 3% or DSI 4% for term infants and 
therefore we have no comparison data for our population of premature infants. The one 
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reported desaturation index of DSI 4% >10 seconds was significantly lower in term infants 
than preterm infants. Results from studies that report mean SpO2 and time spent below 
90% SpO2 suggest that these two measures are not significantly different between term 
infants and preterm infants when they reach term equivalent age. These few studies 
suggest that while mean SpO2 does not differ between term infants and convalescent 
premature infants at term equivalent age, there are higher rates of intermittent hypoxia in 
the preterm group.  
 
The degree of intermittent hypoxia that these convalescent preterm infants are 
experiencing would be considered pathological if put in an adult context. Sleep apnoea is 
often defined by AHI (apnoea hypopnoea index). In adults the AHI is the number of 
pauses in breathing lasting 10 seconds or more that are associated with a desaturation per 
hour. An AHI > 5 events/h is considered diagnostic of sleep apnoea, with severe sleep 
apnoea defined as an AHI > 30. Chung et al. looked at the correlation between desaturation 
index from pulse oximetry and AHI from PSG (184). Nonin oximeters were used and had 
an averaging time of 3 seconds, and reports were generated through PROFOX software 
using the automatic editing function. Good correlation was found between DSI 4% >10 
(referred to as the ODI – oxygen desaturation index) and AHI, with ODI >5 events/ h 
correlating with AHI >5 events/h (184). Romem et al. reported this correlation also (185). 
Niijima et al. reported that a DSI 4% of >10 events per hour was associated with a 
diagnosis of sleep apnoea (186). In children, the AHI is derived differently with apnoea 
defined as two missed breaths or longer. An AHI of less than one event per hour is 
considered to be normal, an AHI of 1-5 is mildly increased, 5-10 moderately increased, 
and greater than 10 is moderately severe with treatment generally indicated for AHI >5 
(187). Roberts et al. studied a preterm infant population and reported a positive correlation 
between AHI and both DSI 3% (p = 0.003) and DSI 4% (p = 0.0008) (188).  
	
Our median DSI 4% > 10 seconds in our population was 10.7 events/ h, so if correlating 
this to AHI, the majority of our participants would be diagnosed with sleep apnoea based 
on both adult and paediatric criteria.  
6.1.2 Artefact editing 
During the progression of this thesis, data from the infant 24-hour oximetry reports were 
noticed to have a lot of apparent artefact, and many fleeting oxygen desaturations that were 
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hard to assess as to whether they were artefact or in fact true desaturations. The editing of 
infant oximetry reports is certainly a lot more complex than when editing adult reports. 
This is because infants desaturate more quickly than adults due in part to their small 
pulmonary reserve, meaning that sharp steep desaturations that would be defined as clear 
artefact when seen in adult oximetry reports, cannot be as easily accepted as artefact when 
they occur in infant oximetry reports (49).  
	
Previous studies were reviewed to establish how to best edit oximetry data in this 
population. Table 3-1 in Chapter three presents this information. There was a lack of 
reproducible editing methods described, with 3/11 studies reviewed not reporting any 
editing and of the remaining studies that did report some editing, it was often vaguely 
described using phrases such as ‘areas of artefact were excluded’. Of the three studies that 
used PROFOX software, all three used the automatic editing function to delete low signal 
IQ. Two of the three studies also reported that they manually screen desaturations to 
exclude any that were artefactual; however, how they identified an artefactual event 
compared to a real desaturation from within the oximetry data was not described, therefore 
making it impossible to determine what were considered artefactual events. We therefore 
created our own set of manual editing rules, based on data available on what is 
physiologically possible as discussed in section 3.2.  
	
The manual editing of data as per the rules we created, we believed produced the most 
accurate oximetry reports for these infants and there were statistically significant 
differences between most measures reported from the manually edited oximetry reports 
compared with unedited reports, as well as many measures from the automatically edited 
report.  
 
The median length of recording time that was excluded from oximetry reports after editing 
was a lot less when manually edited compared to automatic editing (13 minutes vs 1 hour 
42 minutes). This suggests that automatically editing oximetry reports does exclude a lot of 
data that is in fact considered real when taking the time to manually edit, suggesting that 
manual editing of oximetry reports is a far more refined method than simply using the 




Manual editing however is time consuming, and requires some expertise so to be able to 
justify spending time manually editing reports, there would have to be clinically significant 
differences in the oximetry reports produced. Although there were statistically significant 
differences seen between edited and unedited reports as well as between manual editing 
and automatic editing, the only measures with clinically significant differences (we used a 
change of >10% as a measure of clinical significance) between unedited and edited 
(manual and/or automatic) reports were: pulse nadir, time spent below 90% SpO2 and DSI 
4% >10 seconds. 
 
For percentage time spent <90% SpO2 there was a clinically significant improvement (i.e 
the percentage time spent below 90% SpO2 decreased) after both automatically and 
manually editing reports. Manual editing produced a slightly larger improvement 
compared with automatic editing, but the difference between the two ways of editing 
(manual and auto) was not of clinical significance.  
 
For DSI 4% >10 seconds, there was only a clinically significant improvement after 
automatically editing data, with no significant change after manual editing. This indicates 
that automatically editing reports can underestimate the severity of DSI 4% > 10 seconds, 
as it improves the value compared with manual editing where DSI 4% >10 seconds 
remains unchanged from unedited reports.  
 
For pulse nadir, manual editing produces a great improvement (median of >100% change), 
and automatic editing doesn’t produce any median change; therefore, automatically editing 
data can overestimate how severe the lowest pulse is (compared with manual editing).  
 
The median SpO2 nadir did not change by more than 10% between types of editing. When 
looking at individual reports, the SpO2 nadir either doesn’t change at all (60.5% of cases), 
or changes by a large amount. Of the cases where the SpO2 nadir does change, the median 
change from raw to automatically edited reports was 21.9% (4.5% – 231%), and to 
manually edited was 29.5% (4.1% – 427.2%). This shows that either way of editing often 
does improve the SpO2 nadir by a clinically significant amount, and manual editing often 
improves the nadir by a greater value. The change in SpO2 nadir after editing is always an 
improvement (increase), as artefact can often cause a single very low SpO2 value. 
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Therefore, in a significant percentage of cases, the SpO2 nadir does improve by a clinically 
significant amount after editing.  
	
Overall, manual editing improves the percentage time spent below 90% SpO2, the SpO2 
nadir, and pulse nadir. Automatically editing of the recordings can produce clinically 
similar improvements to manual editing in time spent below 90% SpO2 and SpO2 nadir; 
however, automatic editing also clinically improves (reduces) DSI 4% >10 seconds (which 
manual editing does not), and does not improve the pulse nadir like manual editing does.  
	
We can be reassured that the clinically significant changes to reports after manual editing 
are of a clinical improvement in measures (compared to unedited reports). This means that 
if unedited reports are used, clinicians may overestimate how bad the infant’s respiratory 
status is. This could result in infants being kept on additional oxygen for longer or delaying 
discharge home, rather than undertreating these infants.  
 
As can be seen, the value of manual editing is limited. The majority (7/10) of measures 
reported on the oximetry reports were clinically similar to the unedited oximetry reports. 
Automatically editing oximetry reports gives clinically similar results to manual editing in 
the majority of measures (8/10 of reported measures). Manual editing is time consuming, 
taking between 5 to 20 minutes per report, while automatic editing takes less than 30 
seconds to perform. In view of the time taken to perform manual editing, automatic editing 
is a reasonable alternative to manual editing as it does improve percentage time spent 
<90% SpO2 similarly to manual editing, while pulse nadir and DSI 4% >10 seconds are 
measures to be wary of if automatic editing is performed, as results for these two measures 
were clinically different from manual editing.   
	
6.1.3 24-hour vs 12-hour ‘overnight’ recordings 
When comparing the full 24-hour recordings with the edited ‘overnight’ recordings, 
statistically significant changes were seen. However, apart from pulse nadir, all of the 
differences were less than 5%, which is very unlikely to make any clinical difference when 
interpreting the reports. Therefore, apart from again being wary of the reported nadirs, a 
full 24-hour oximetry recording does not seem to offer any added value over a 12-hour 




We considered the effect of only using overnight recordings on the accuracy of reporting 
an infant’s overall respiratory status. Adults generally sleep during the night, and are 
awake during the day, and as sleep has a significant effect on their respiratory status and 
oxygen levels, an overnight recording in this population would give significantly different 
reports to a daytime recording. Infants of this age however, generally wake to feed and 
then sleep, approximately every four hours, with no apparent day/night rhythm. During the 
day infants may be more disturbed with noise and procedures particularly in the NICU 
environment. We have only compared full 24-hour recordings with overnight recordings, 
and not 12-hour daytime recordings with 12- hour night time recordings, however we do 
not believe a daytime recording would give different results to a ‘overnight’ recording in 
this population, as both time periods would capture sleep and wake periods equally for 
preterm infants. This is however a hypothesis, and is therefore a possibility for future 
research.  
6.1.4 Follow-up study 
i. One month post discharge oximetry recordings 
When comparing discharge oximetry recordings with recordings one month post discharge, 
there were significant improvements noted in all intermittent hypoxia measures, but no 
change in mean SpO2. The changes where substantial, with desaturation indices falling by 
around 42.7% - 57.4%. For example, the median number of desaturations per hour of 4% 
or more per hour was 57.9 at discharge and 25.5 one month later. This suggests that 
measures of intermittent hypoxia are better indicators of respiratory stability over time than 
mean SpO2, as while the desaturation indices improved over time the mean SpO2 remained 
the same. 
	
Only one other reported study in the literature has studied change in oximetry results over 
a similar time period. Poets et al. published a paper in 1992 that compared discharge 
oximetry from convalescent preterm infants to oximetry performed 6 weeks post 
discharge. This study used Nellcor N100 oximeters and the recordings were printed on 
graph paper and had to be analysed and scored manually. Median SpO2 was 99.5%  (range 
88.7 – 100) at discharge and 100% (95.3 – 100) 6 weeks later, while intermittent hypoxia 
(measured by number of desaturations per recording to ≤80% SpO2 for ≥ 4 seconds) 
improved from a median of 3 (0 – 255) per recording to a median of 0 (0 – 17) per 
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recording (90). Although these data were collected on now out-dated oximeters and used a 
very different definition of IH, the trend in results is consistent with our results, with mean 
SpO2 not changing and IH measures improving significantly.   
	
These results show that respiratory stability in premature infants improves rapidly with 
advancing maturity. This indicates that a premature infant’s degree of respiratory stability 
at discharge home from the neonatal unit is still immature, as the amount of intermittent 
hypoxia experienced still declines significantly after discharge without any specific 
treatment or intervention.   
ii. Post discharge growth rates 
No correlation was found between growth rates (measured by change in weight Z-score) 
with degree of intermittent hypoxia at discharge. Our hypothesis was that there would be a 
correlation between the two with those infants with the more marked IH exhibiting a 
degree of growth failure in the first month after discharge. Physiologically, as discussed in 
section 2.1, there is reason to believe that growth would be affected by intermittent 
hypoxia. One reason this was not seen here could be simply the low numbers of 
participants in this section of the study. Repeating this study with a larger participant 
number of participants that generated enough power would be necessary to be able to 
confidently conclude there is no correlation. Another reason could be that infants that 
experience more intermittent hypoxia, and therefore more energy expenditure, could 
compensate for this by increasing their energy intake by consuming more milk, therefore 
weight gain would be maintained. There are many other factors that contribute to weight 
gain after discharge, such as how often an infant is fed, what type of milk it is given and 
any other concurrent illnesses. Although these factors were recorded at each weekly follow 
up visit for growth, the sample size is too small to be able to account for these potential 
cofounders, and therefore this could be a reason no correlation was seen.  
6.2 Strengths and limitations 
There were some limitations to this study. As mentioned, when trying to appreciate the 
significance of such apparent severe intermittent hypoxia values, comparison with normal 
term infants is required. This study did not include a comparison group, which would 
ideally be of healthy term infants > 48 hours old. This would have enabled these results to 
be appreciated in context of ‘normal’ expected values of term infants. We were able to 
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compare some of our measures with previously reported values in the literature for term 
infants, but normal values for term infants for DSI 3% and DSI 4% have never been 
reported in the literature. The difficulty with the comparison group is that healthy term 
infants do not stay in hospital very long at all, so to be able to get consent and perform a 
24-hour study before discharge home would be very difficult. A solution to this is to gain 
consent as soon as the infant is born and visit the infant at their home within their first 
week of life to perform a 24-hour oximetry. This was not practical with the current study in 
the timeframe available.   
 
The follow up period of one-month is short when wanting to consider any future morbidity 
of intermittent hypoxia in infancy. Ideally a follow up period of a number of years is 
needed to be able to see any meaningful impact on growth and neurodevelopment. This 
study was limited to one year, and therefore a one-month follow up period was all that was 
practical. Investigating growth as a potential impact of IH in premature infants has never 
been reported before, and therefore this follow up section of the study was considered a 
pilot study. As mentioned, the small numbers in this follow up group was also a limitation.  
 
Although artefact was thoroughly considered and an attempt was made to best exclude 
any, there is still the potential for recordings to contain artefact even after manual editing. 
This is in part due to having only one parameter recorded (pulse oximetry), and there are 
no other channels such as a pulse waveform, ECG, or nasal airflow to be able to relate each 
desaturation too. This should be taken into account if ever comparing these desaturations 
values from this study with full PSG recordings. The values from this study however are 
designed to be used when interpreting pulse oximetry rather than PSG.  
	
This study has many strengths, including the use of new generation oximeters with 2 
second averaging time and PROFOX software. These are the most commonly used 
oximeters and software in NZ and Australia therefore the results from this study are highly 
relevant for current clinical practice compared to older studies using older, less accurate 
oximeters (69). As mentioned, presenting ‘normal’ ranges three alternate ways (unedited, 
automatically edited and manually edited) makes these results more widely applicable. The 
appreciation of the degree of artefact in these oximetry recordings is also a strength, as 
many previous studies appear to have not considered the potential impact of artefact on 
results.  
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6.3 Clinical recommendations and implications 
6.3.1 Artefact and editing oximetry reports 
In general the findings in this study support a recommendation that editing should be 
performed on oximetry reports to be able to exclude artefact. Automatic editing is a good 
option for busy clinicians as although manual editing does produce the most accurate 
reports, there are limited advantages for the large time commitment. If interpreting 
automatically edited reports, clinicians need to be aware that the pulse nadir may be 
artefactual and in fact be a lot higher, and that DSI 4% > 10 seconds may be lower than if 
manual editing has been used. The DSI 3% and DSI 4% values do not differ between types 
of editing, so are perhaps a more robust measure to consider when quantifying intermittent 
hypoxia.    
 
If using unedited oximetry reports, the majority of measures are reliable; however, when 
looking at the percentage time spent <90% SpO2, clinicians need to be aware that this 
value could be overestimated due to artefact in the recording. If using this measure to aid 
clinical decision-making, editing may be warranted to produce a more accurate value, 
especially if the value is borderline for clinical thresholds (e.g if using the British Thoracic 
Society Guidelines of 5% as being acceptable (74), and the percentage time for the infant 
is say 6%, editing is warranted to be certain that the percentage time spent below 90% 
SpO2 is in fact > 5%.)  
 
When analysing oximetry reports, clinicians need to be aware that the nadir (both pulse 
and SpO2) have a high chance of being artefactual. If using these measures in clinical 
interpretation and they are worryingly low, editing is useful to be certain that the value is 
not a product of artefact. Automatic editing is a good first line option to see if the nadir 
improves. If not, manual editing would be useful to visually view the nadir and decide if it 
is part of artefact, or it is in fact the true lowest drop in the recording.  
6.3.2 12 hour vs 24 hour oximetry 
We have demonstrated that 12-hour overnight oximetry reports are clinically very similar 
to reports produced from full 24-hour oximetry recordings and therefore are an adequate 
alternative. Setting up an infant with an oximeter just for the overnight period rather than 
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for a full 24-hours would be more acceptable to both parents and medical staff, as less 
procedures are performed and an infant is generally moved less at night. Therefore, we 
recommended performing overnight oximetry rather than 24-hour oximetry, as it is less of 
a disturbance and produces similar reports.  
6.3.3. General recommendations 
Desaturation index (DSI 3% / DSI 4%) is rarely reported in the literature, and it appears 
clinicians are focusing on mean SpO2 and time spent below 90% when interpreting 
oximetry reports for infants. We suggest there is value in desaturation indices, and they 
should be reported and considered more often. We have shown that the desaturation index 
decreases with advancing PMA, while mean SpO2 does not, indicating that desaturation 
indexes are a more sensitive measure of respiratory stability.  
  
There is the question of whether neonatal units should be routinely screening premature 
infants with pulse oximetry at discharge home from the neonatal unit. Although we have 
shown these infants are still experiencing a large, and possibly concerning degree of 
intermittent hypoxia, there is currently not enough evidence in regard to the consequences 
of high desaturation indices reported from pulse oximetry to decide whether something 
should be done to decrease this amount of intermittent hypoxia or not. In view of this, 
before good evidence exists, we would suggest that routine oximetry screening at 
discharge cannot yet be universally recommended, as it is hard to interpret the significance 
of any results obtained.   
6.4 Directions for future research  
As indicated previously, long-term studies looking at the effect of intermittent hypoxia 
(measured by pulse oximetry) on preterm infant growth and neurodevelopmental are 
needed. This will enable much needed, precise guidelines to be developed to aid clinician 
interpretation of pulse oximetry and decision making for treatment of respiratory 
instability. Infants from this study have the potential to be used for a follow up study, as 
discharge oximetry recordings have already been performed. The apparent trend of time 
<90% SpO2 having a negative relationship to postnatal growth could indicate that this 
particular oximetry measure (times spend <90% SpO2) could be a focus for future 
research.    
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All studies investigating premature infants and neurodevelopmental outcome are 
complicated by many potential cofounders. Premature infants often experience many 
adverse events such as IVH, jaundice, and NEC, and are also at higher risk of impaired 
neurodevelopment. Infants with more frequent intermittent hypoxia may have experienced 
more serious medical events, and therefore it is difficult to establish whether it is purely 
the intermittent hypoxia causing decreased neurodevelopment, or if the other factors had 
already predisposed them to worse neurodevelopment. Randomised control trials of 
treatment options for intermittent hypoxia, such as extended caffeine treatment, are needed 
to be able to determine the true significance of intermittent hypoxia, as if 
neurodevelopment improves with treatment of IH, that would provide a clear indication 
that ongoing IH does have some influence on neurodevelopment. An example is a study 
that would randomise preterm infants to either receive caffeine treatment for one month 
post – discharge, or discontinue caffeine at the currently accepted time, and then compare 
long term neurodevelopmental outcome between the two groups. This type of study would 
provide evidence as to whether we should be concerned about treating the seemingly 
severe intermittent hypoxia this study has exposed.  
 
Studies reporting normal desaturation indices for term infants are also needed, as no study 
to our knowledge reports DSI 3% and DSI 4% for healthy term infants in the first week of 
life. This literature is needed in order to be able to better understand the described 
premature infant desaturation indexes.  
	
6.5 Conclusion 
This study has shown that intermittent hypoxia is frequent in preterm infants and given 
reference ranges for expected values at discharge in preterm infants. It has shown that rates 
of IH decline significantly in the one-month post discharge. This study has also established 
that automatic editing is a good alternative to manual editing, although both pulse nadir 
and SpO2 nadir values are to taken with caution as they are often caused by artefact. The 
study has shown that 12-hour overnight oximetry recordings are comparable to full 24-
hour recordings and therefore would be a favourable alternative as overnight recordings 
are more practical. The long-term natural history of the clinical phenomenon of IH is still 
to be established.  Future research is needed to determine what this means for preterm 
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Test date: 04/22/15 Start: 04/22/15 11:54:28 baby#17       
Doctor:                       End: 04/23/15 09:14:44 ID#: 17       
Oximetry: Comprehensive Report
      Recording time: 21:20:16      Highest pulse: 225              Highest SpO2: 100%
   Excluded sampling: 00:25:18       Lowest pulse:  54               Lowest SpO2:  73%
Total valid sampling: 20:54:58         Mean pulse: 164                 Mean SpO2:  97.9%
                            Time with SpO2<90:  0:07:22,   0.6%
                            Time with SpO2<80:  0:00:34,   0.0%
                            Time with SpO2<70:  0:00:00,   0.0%
                            Time with SpO2<60:  0:00:00,   0.0%
                            Time with SpO2<88:  0:04:18,   0.3%
The longest continuous time with saturation <=88 was 00:00:36, which started at
04/23/15 01:57:38.
         When a desaturation was defined as a decrease of:      4%      3%      2%
               Total number of events less than 3 minutes:     506     949    1921
                Number of events excluded due to artifact:       0       0       0
                 Number of events over 3 minutes duration:      12       9       2
                               Mean high event saturation:    99.1    99.0    98.8
                               Mean  low event saturation:    92.9    94.2    95.5
  The mean length of events >=10 sec & <= 3 mins, in secs:    42.5    39.3    26.1
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Test date: 04/22/15 Start: 04/22/15 11:54:28 baby#17       
Doctor:                       End: 04/23/15 09:14:44 ID#: 17       
Oximetry: Summary Report
      Recording time: 21:20:16      Highest pulse: 225              Highest SpO2: 100%
   Excluded sampling: 00:25:18       Lowest pulse:  54               Lowest SpO2:  73%
Total valid sampling: 20:54:58         Mean pulse: 164                 Mean SpO2:  97.9%
                                           1 S.D.:  18.5                  1 S.D.:   1.9
Time with SpO2<90:  0:07:22,   0.6%           Time with SpO2      =>90: 20:47:36,  99.4%
Time with SpO2<80:  0:00:34,   0.0%           Time with SpO2=>80 & <90:  0:06:48,   0.5%
Time with SpO2<70:  0:00:00,   0.0%           Time with SpO2=>70 & <80:  0:00:34,   0.0%
Time with SpO2<60:  0:00:00,   0.0%           Time with SpO2=>60 & <70:  0:00:00,   0.0%
Time with SpO2<88:  0:04:18,   0.3%
The longest continuous time with saturation <=88 was 00:00:36, which started at
04/23/15 01:57:38.
         When a desaturation was defined as a decrease of:      4%      3%      2%
               Total number of events less than 3 minutes:     506     949    1921
                Number of events excluded due to artifact:       0       0       0
                 Number of events over 3 minutes duration:      12       9       2
                               Mean high event saturation:    99.1    99.0    98.8
                               Mean  low event saturation:    92.9    94.2    95.5
       The number of events that were  > 0 & < 10 seconds:     278     500    1116
                                      =>10 & < 20 seconds:      89     161     415
                                      =>20 & < 30 seconds:      35      84     178
                                      =>30 & < 40 seconds:      25      55      80
                                      =>40 & < 50 seconds:      12      35      36
                                      =>50 & < 60 seconds:      14      29      32
                                      =>60        seconds:      53      85      64
  The mean length of events >=10 sec & <= 3 mins, in secs:    42.5    39.3    26.1
  Desaturation event index (events >=10 seconds per hour):    10.9    21.5    38.5
  Desaturation event index (events >= 0 seconds per hour):    24.2    45.4    91.8
© 2011 PROFOX Associates, Inc.  Oximetry version Masimo RD2011.00-1070







Manager, Academic Committees, Mr Gary Witte
H15/013
Professor D Elder
Department of Paediatrics and Child Health (Wgnt)
Children’s Hospital, Wellington Hospital
University of Otago, Wellington 
Dear Professor Elder,
I am again writing to you concerning your proposal entitled “24-hour oxygen saturation
recordings at discharge in preterm infants”, Ethics Committee reference number H15/013.
Thank you for your letter of 21st February 2015 addressing the issues raised by the
Committee.
The Committee thanks you for providing the Peer Review undertaken by Professor Nicola
Austin and the locality agreement from the Child Health Governance Group at Capital and
Coast District Health Board.
In respect of the issue regarding not passing on relevant information; the Committee notes
the letter of support provided by Dr Vaughan Richardson, Clinical Leader, Neonatal Intensive
Care Unit at Wellington Regional Hospital and also accepts the further justification provided
for not passing on information stating that ‘ .. there is not yet a solid evidence base for
making changes to patient management based on the determination that there is intermittent
oxygen desaturation over a 24 hour period when the infant is otherwise regarded as healthy
and fit for discharge.’
The Committee notes that you have made a number of changes to the Information Sheet to
ensure that participants understand that the research team will not be influencing decisions
about a participant's readiness to be discharged.
On the basis of this response, I am pleased to confirm that the proposal now has full ethical
approval to proceed.
The standard conditions of approval for all human research projects reviewed and approved
by the Committee are the following:
Conduct the research project strictly in accordance with the research proposal submitted and
granted ethics approval, including any amendments required to be made to the proposal by




Inform the Human Research Ethics Committee immediately of anything which may warrant
review of ethics approval of the research project, including: serious or unexpected adverse
effects on participants; unforeseen events that might affect continued ethical acceptability of
the project; and a written report about these matters must be submitted to the Academic
Committees Office by no later than the next working day after recognition of an adverse
occurrence/event. Please note that in cases of adverse events an incident report should also
be made to the Health and Safety Office:
http://www.otago.ac.nz/healthandsafety/index.html
Advise the Committee in writing as soon as practicable if the research project is discontinued.
Make no change to the project as approved in its entirety by the Committee, including any
wording in any document approved as part of the project, without prior written approval of the
Committee for any change. If you are applying for an amendment to your approved research,
please email your request to the Academic Committees Office:
gary.witte@otago.ac.nz
jo.farrondediaz@otago.ac.nz
Approval is for up to three years from the date of this letter. If this project has not been
completed within three years from the date of this letter, re-approval or an extension of
approval must be requested. If the nature, consent, location, procedures or personnel of your






 c.c. Professor D Elder    Department of Paediatrics and Child Health (Wgnt)
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Appendix C Infant characteristics 
 
Antenatal information collected:  
- Maternal smoking 
- Use of antenatal steroids (including whether a full (double) dose, partial dose or 
multiple doses had been given) 
- Length of rupture of membranes 
- Presence of chorioamnionitis (including if it had been confirmed on histology or 
was just suspected from swabs) 
- Presence of multiple gestations including any twin-to-twin transfusion syndrome 
(TTTS) and birth order 
 
Birth and resuscitation information collected: 
- Gestation at birth 
- Method of delivery 
- Condition of the infant at birth (including APGARS and resuscitation notes) 
- Infant birth weight, head circumference and length. 
- The CRIB score was calculated (birth weight, gestational age, the presence of 
congenital malformations, worst base excess, maximum and minimum appropriate 
fraction of inspired oxygen (FIO2) during the first 12 h of life) 
 
Postnatal information collected: 
- The number of days the infant was on respiratory support (including number of days 
intubated, on CPAP, on oxygen, and on caffeine) 
- The number of days the infant was on cardiorespiratory monitoring and reports of any 
24-hour oximetry studies done on the infant during their stay/as a pre-discharge check 
as part of normal NICU assessment were photocopied.    
- Use of any steroids 
- Number of blood transfusions the infant had during their stay in NICU 
- Highest serum bilirubin (SBR) during their stay in NICU  
- Relevant medical conditions: PDA and treatment (medical or surgical), CLD, 
persistent pulmonary hypertension of the newborn (PPHN), sepsis at any point, reflux 
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(had to be medicated), IVH and severity, PVL and severity, ROP and severity, and if 
the infant had any surgery during their stay.  
 
Information on the infant at time of discharge oximetry: 
- Infant PMA at time of study 
- Method of feeding 
- Type of milk (Formula/EBM) 
- Current us of supplemental oxygen and amount 
- Most recent haemoglobin and SBR levels and date of these 
- Any current medical issues 
- Documentation of clinical concern about apnoea  
- Number of days until discharge  (from the completion of the 24-hour recording) 
	
	
